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CHAPTER I 
 
INTRODUCTION 
 
Introduction 
 The exciting field of ion channel biology has exploded in recent years.  New 
structural techniques have yielded an amazing amount of information about the mecha-
nisms of various aspects of channel function, including gating, selectivity, and drug/toxin 
interactions.  The studies presented in support of this dissertation were undertaken to 
structurally and biochemically characterize the regulation of the human voltage-gated so-
dium channel hH1 (NaV1.5) by calcium.  The findings are interesting in that they are the 
first evidence that calcium directly regulates voltage-gated sodium channel function by 
binding to an element in the polypeptide chain of the channel itself.  Moreover, they re-
veal crosstalk between this intrinsic calcium sensing pathway and an extrinsic calcium 
sensing pathway mediated by calmodulin.  This introductory chapter is designed to con-
vey a basic understanding of ion channel function at the molecular and cellular level.  
This chapter also summarizes some of the evolutionary and structural information cur-
rently known about ion channels, and discusses drugs, toxins, and proteins which are 
known to modulate hH1 function.  Naturally occurring mutations in hH1 and their effects 
are examined.  Finally, basic biochemical characteristics of a common calcium binding 
motif, the EF-hand, are discussed in detail.  This background serves as a springboard for 
understanding the rationale behind the experiments described in the rest of the thesis. 
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Ion channels are responsible for mediating a wide range of normal physiology  
 
Ionic currents mediate muscle and nerve cell excitability 
 It has been known since the late 1800’s that ions are critical for, and can be used 
to manipulate, the normal functioning of nerve and muscle cells.  A series of frog heart 
perfusion studies done by Sidney Ringer in the 1880’s revealed that a mixture of sodium 
(Na+), potassium (K+), and calcium (Ca2+) ions, each in a relatively narrow range, was 
required for maintaining heartbeat (Hille 1992).  In the ensuing half-century, numerous 
hypotheses were developed and tested with regards to the nature of cellular electrophysi-
ology.  Julius Bernstein proposed early in the 20th century that resting cell membranes are 
selectively permeable to K+ ion, and that excitation is both mediated by and results in 
changes to this selective permeability (Hille 1992).  The work done by Hodgkin and Hux-
ley in the early 1950’s (Hodgkin and Huxley 1952a; Hodgkin and Huxley 1952b), using 
the squid giant axon as a model system, demonstrated specific Na+-dependent and K+-
dependent currents across the cell membrane.  These studies firmly established the con-
cept that ion-selective channels exist and give rise to the excitability of muscle and nerve 
cells by producing an action potential across the cell membrane, and included a detailed 
model of the changes in selective permeability that occur over the course of an action po-
tential. 
 Since the now classic work of Hodgkin and Huxley, advances in fields spanning 
genomics, electrophysiology, structural biology, and medicine have identified hundreds 
of these selective ion channels in humans, established the mechanism by which cells 
maintain ion gradients across the cell membrane and produce an action potential in re-
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sponse to stimulation, and found that a large number of disease causing mutations affect 
these channels.  A high visibility example of the latter is CFTR (“cystic fibrosis trans-
membrane conductance regulator”); mutations in this secretory chloride channel result in 
cystic fibrosis, the most common fatal genetic disease (Quinton 1990). 
 
Action potentials are the basic unit of excitability 
 Since the action potential is the basic currency of excitability in muscle and nerve 
cells, it is important to examine this process in more detail to provide a framework for the 
studies that will be described later.  While the details of this process can be found in any 
basic physiology textbook, the description employed here is that of Bertil Hille in Ionic 
Channels of Excitable Membranes (Hille 1992). 
Prior to an action potential, the cell is said to be at rest (Figure 1.1a,b).  At rest, 
cells expend energy in the form of ATP to drive a Na+/K+ exchanger, which translocates 
3 Na+ ions from inside of the cell to the outside while simultaneously translocating 2 K+ 
ions from outside to the inside.  This exchanger is responsible for maintaining the high 
relative concentration of K+ inside the cell (large K+) and the high relative concentration 
of Na+ outside the cell (large Na+).  At rest, the membrane experiences slight, selective 
leakage of K+ ion, which establishes a resting membrane potential of approximately -90 
mV (as can be calculated using the Nernst equation given the extracellular and intracellu-
lar concentrations of K+).  This resting membrane potential can vary from minute to min-
ute or hour to hour in the same cell due to alterations in the ratio of intracellular to ex-
tracellular potassium.  These variations in membrane potential are important for reasons 
that will be discussed shortly. 
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Figure 1.1: The roles played by voltage-gated sodium and potassium channels in the 
generation of an action potential. (a) Typical cardiac myocyte action potential showing 
transmembrane potential as a function of time.  Baseline potential is around -90 mV, and 
peak positive potential can be as high as +40 mV.  Circled letters show, generally, the 
relationship between the transmembrane potential shown in this panel and the channel 
states shown in panels b-e. (b-e) Open, closed, or inactivated state of sodium and potas-
sium channels during an action potential.  See text for details.   
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 At rest, voltage-gated Na+ and K+ channels are in the closed state.  An action po-
tential is initiated by a small depolarization of the cell membrane, e.g. a change in the 
potential across the cell membrane from -80 mV to -40 mV.  Following the initiation of 
the action potential, voltage-gated Na+ channels “gate” open in response to the voltage 
change (Figure 1.1c), allowing Na+ ions to rush into the cell across their concentration 
gradient.  This results in further depolarization of the cell membrane, resulting in trans-
membrane potentials as high as +40 mV.   
 At this point in the process, Na+ channels begin to inactivate, while voltage-gated 
K+ channels, some of which gate slowly, begin to open.  This reverses the direction of 
change in the transmembrane potentials and leads to repolarization of the cell membrane 
(Figure 1.1d).  Another set of potassium channels also contributes to repolarization; these 
“fast delayed rectifier channels” gate open quickly with the Na+ channels, but inactivate 
very quickly as well.  Late in the action potential, these channels begin to recover from 
inactivation and contribute to repolarization.  Repolarization may end in undershoot, 
which would be at the point shown in Figure 1.1e; it is not present here because cardiac 
ventricular myocytes do not typically exhibit undershoot.  In undershoot, the cell is 
mildly hyperpolarized and is in a refractory period during which it cannot fire another 
action potential until channels recover from inactivation.  The cell then re-establishes the 
resting membrane potential and readies itself for the next action potential.  The entire cy-
cle from beginning to end occurs in less than half a second in cardiac myocytes depend-
ing on heart rate; in neurons, at any point along an axon, the propagation of an action po-
tential through that point can occur in under 5 milliseconds. 
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It is critically important to understand that “inactivated” channels are very differ-
ent from “closed” channels in at least one fundamental respect: their ability to gate open 
in response to a voltage signal.  As we saw earlier, closed channels gate open; inactivated 
channels DO NOT.  Thus, in Figure 1.1 we differentiate between channels in the closed 
state (flat-top, small hole) versus channels in the inactivated state (beveled top, small 
hole).  While the cell is repolarizing and during the undershoot phase, a preponderance of 
channels on the cell membrane are in the inactivated state.  The cell is in a refractory pe-
riod, unable to respond to a voltage pulse with an action potential. 
With the difference between inactivated and closed channels well-defined, we 
must return to the point that the resting membrane potential can vary from minute to 
minute or hour to hour.  It is important to note that even at rest, a proportion of channels 
are in the inactivated state (versus those in the closed state).  The ratio is modulated in 
part by the resting membrane potential, a phenomenon termed voltage-dependent steady-
state availability; this phenomenon will play a prominent role in the electrophysiological 
data to be described in this dissertation. 
The Hodgkin/Huxley model was a groundbreaking analysis of the action poten-
tial, providing a rigorous mathematical description of this time-dependent phenomenon.  
Its importance for both describing and understanding the fundamental behavior of excit-
able membranes cannot be understated.  An excellent overview of this model can be 
found in Hille’s treatise (Hille 1992). 
Where does the initiating voltage pulse originate?  While there are many potential 
sources, it has been observed that ligand-gated ion channels are a common and important 
source for the initial depolarization.  For example, the nicotinic acetylcholine (nAChR) 
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receptor is found at the neuromuscular junction and is stimulated to gate open by its 
ligand, the molecule acetylcholine.  This channel nonspecifically conducts monovalent 
and divalent cations, including Ca2+, Na+ and K+ (Takeuchi and Takeuchi 1960; Takeuchi 
1963a; Takeuchi 1963b), providing the initial depolarization event leading to an action 
potential in muscle cells.  The action potential across the myocyte then stimulates the 
phenomenon known as excitation-contraction coupling, in which muscle cells translate 
the biochemical changes caused by the action potential into muscular contraction. 
Ligand- and voltage-gated ion channels can be contrasted with another class of 
membrane proteins called receptors.  Unlike ion channels, receptors do not conduct ions.  
Rather, receptors bind their ligand and transmit a signal to the other side of the mem-
brane.  The signal is then propagated by second-messengers like adenosine 3’,5’-
monophosphate (cyclic AMP, cAMP) or inositol 1,4,5-triphosphate (IP3).  A widespread 
superfamily of receptors are G-protein coupled receptors (GPCRs), which bind a variety 
of ligands and mediate, among other things, a diverse set of hormonal responses.  GPCRs 
can, in some cases, modulate the function of ion channels (Kim et al. 1989; Kurachi et al. 
1989), adding to the complexity of excitable systems. 
 
Evolutionary analysis of genetic data reveals families of ion channels 
 A large number of voltage-gated ion channels, primarily conducting Na+, K+, and 
Ca2+, can be found in the human genome.  These genes share significant homology with 
one another and likely result from gene duplication events allowing for specialized ex-
pression, subcellular localization, and regulation of channels able to conduct the same 
ion.   
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Potassium channels are generally formed by homotetrameric α4 structures in 
which each α subunit contains six transmembrane (TM) spanning helices.  These chan-
nels are thought to be the oldest, evolutionarily speaking.  In many cases, the homo-
tetramer is tightly associated with a β subunit which modulates function.   
 
 
Figure 1.2:  Overall domain structure and transmembrane topology of voltage-gated so-
dium and calcium channels.  The location of the IFM motif is indicated by an arrow. 
 
 
   
The primary α subunits of sodium and calcium channels, on the other hand, are 
about four times larger than the potassium channel and are basically the equivalent of a 
potassium homotetramer, linked into a single polypeptide chain by hydrophilic loops.  
The predicted domain structure and transmembrane topology of the alpha subunits of 
these channels are identical across all human members of this family (Figure 1.2).  The 
alpha subunit is a single large polypeptide (~2000 residues) with four transmembrane 
domains connected by cytoplasmic (intracellular) linkers of varying length.  The N- and 
C-termini are also on the cytoplasmic side of the cell membrane.  Each transmembrane 
domain is denoted by a Roman numeral (I, II, III, IV) and is comprised of six transmem-
brane helices.  There is also a pore-forming loop, conformationally found in the plane of 
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the membrane, between transmembrane helix 5 (also known as segment 5 or S5) and 
transmembrane helix 6 (S6).  The S4 helices are indicated as a red TM helices in Figure 
1.2.  These are arginine and lysine rich helices, giving each S4 a net positive charge.  
There is substantial evidence that these charges act as the voltage sensor of the channel, 
causing, in response to changes in transmembrane potential, the conformational changes 
that result in channel opening (Bezanilla 2005). 
 
 
Figure 1.3:  The phylogenetic relationship between voltage-gated sodium channel iso-
forms found in humans.  Adapted from (Catterall et al. 2003). 
 
 
 
Although the channels are able to function in heterologous expression systems 
when only the alpha subunit is expressed, all have associated secondary subunits that 
modulate their function.  Sodium channels have two beta subunits, and calcium channels 
have secondary alpha, beta, and delta subunits.  The mechanism by which these associ-
ated subunits operate is unclear, but the number and ubiquitous presence of these subunits 
suggest an important role for these subunits in fine tuning channel behavior in different 
cellular contexts. 
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There are nine human voltage-gated sodium channel isoforms.  These channels 
have been given a systematic designation NaV1.1 through NaV1.9, though each member 
of the family has a number of other, older designations as well.  A tenth member of the 
sodium channel family, designated Nax, has been tentatively identified based on sequence 
homology, but the protein has not been shown to conduct ions in heterologous expression 
systems and further characterization is required.  Figure 1.3 illustrates the phylogenetic 
relationship between these isoforms (Catterall et al. 2003). 
 
Ion channels transition through a series of states during gating 
 While it is certainly possible to imagine a large number of ways in which chan-
nels gate open and then inactivate, most of these can be ruled out by inference from elec-
trophysiological, biophysical, and structural information acquired over the past forty 
years. 
 Perhaps the most important and controversial contribution to our current under-
standing of channel structure and function comes from a pair of studies done by the 
MacKinnon group in 2003 (Jiang, Lee et al. 2003; Jiang, Ruta et al. 2003).  One of these 
papers reported the X-ray crystal structure of a voltage-gated potassium channel, KvAP, 
from Aeropyrum pernix, an archaean hyperthermophilic microbe.  The accompanying 
paper reported the use of an elegant but ultimately flawed antibody-based structural im-
mobilization technique used to elucidate information about the molecular mechanism of 
voltage gating.  Based on their data, Jiang and colleagues hypothesized that the positively 
charged S4 segments act together with part of the S3 segment as a helix-turn-helix “pad-
dle” which traverse as much as 15 Å during activation gating, partially through the mem-
11 
brane lipid bilayer.  This movement causes conformational changes throughout the chan-
nel that result in channel opening. 
The structure itself generated quite a bit of controversy, and it is now generally 
accepted that the published structure is distorted and does not represent the conformation 
of the channel in the lipid bilayer (Bezanilla 2005).  For example, in the KvAP structure, 
the N-terminus and the S1-S2 linker are buried.  This information contradicts years of 
biophysical and mutational work which indicate that the N-terminus is cytoplasmic, and 
the S1-S2 linker extracellular. 
This paddle hypothesis remains controversial and has stimulated a number of fol-
low up studies (Cuello et al. 2004; Bezanilla 2005).  Most of the available evidence sup-
ports a model in which the movement of the S4 segments upon activation gating is rela-
tively small.  Additionally, the energetic costs of ionic movement through even part of 
the lipid bilayer are quite large, and changes in transmembrane potential may not supply 
enough energy to support such a large movement.  Shielding of the S4 charges by bury-
ing them in protein and in hydrated crevasses alleviates the theoretical energetic cost, but 
also changes the model so that it looks more like traditional proposals about the mecha-
nism of activation gating (Ahern and Horn 2004).  Competing hypotheses based on muta-
tional studies have been around for years, and new data will certainly shed further light 
on the subject. 
 
Inactivation gating is a poorly understood phenomenon 
The field of activation gating has advanced quite rapidly as a result of the 
MacKinnon group’s work and the follow up work it has stimulated.  The mechanism of 
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inactivation gating, on the other hand, remains quite opaque.  There is evidence, dis-
cussed below, that in sodium and calcium channels, inactivation is mediated in part by 
the cytoplasmic loops and termini.  Jiang and colleagues removed these cytoplasmic do-
mains in order to crystallize KvAP. 
The limited information that we do have about inactivation gating comes primar-
ily from mutational studies.  A prime contributor to our understanding of inactivation gat-
ing has resulted from genetic analysis and identification of disease causing mutations.  
These studies have revealed, for example, that a critical component of the fast inactiva-
tion gate resides in the tripeptide motif –IFM- found in the III-IV linker of NaV1.5 (West 
et al. 1992).  The location is indicated in Figures 1.2 and 1.4.  The structure of this short 
cytoplasmic domain has been determined by solution state NMR spectroscopy (Rohl et 
al. 1999). 
In addition to fast inactivation, sodium channels experience slow inactivation, a 
process of inactivation that builds up over multiple activation-inactivation cycles.  One 
hypothesis is that extended exposure to depolarized potentials results in additional con-
formational changes which lock the molecule into a “deeper” inactivated state; this lock 
can be released by exposure to hyperpolarized potentials.  We note, however, that slow 
inactivation is even more poorly understood than fast inactivation (Goldin 2003). 
The conformational changes associated with slow and fast inactivation have yet to 
be identified.  The molecular details of inactivation are important not only to understand 
normal physiological processes, but also to understand the mechanism of disease-causing 
mutations and open new therapeutic avenues for those who suffer from these mutations.  
In other words, a better understanding of inactivation may lead to new, better drugs with 
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cardiac and neurological applications.  These drugs could target specific aspects of the 
inactivation machinery to alter electrophysiological properties of cells.  Moreover, iso-
form specific targeting could also result in fewer side effects associated with these pow-
erful and dangerous drugs. 
  
hH1 is a critical voltage-gated sodium channel with cardiac localization 
 
hH1 is an important drug target 
NaV1.5 is a critically important human voltage-gated sodium channel.  This chan-
nel is also referred to in the literature as Scn5a, hH1, and LQT3.  Its gene is found on 
chromosome 3 (locus 3p21) and is expressed primarily in heart muscle cells, where the 
protein is localized to the intercalated discs.  The protein is responsible for the primary 
sodium influx during the depolarization phase of cardiac muscle cell excitation (Figure 
1.1b).  Highlighting the importance of this protein is the fact that a number of drugs and 
toxins target this channel. 
 In the family of voltage-gated sodium channels, nine classes of compounds (en-
compassing both toxins and therapeutic drugs) that alter or block their function have been 
identified.  They have been classified on the basis of the putative site of interaction as 
determined by the electrophysiological effects of these compounds combined with site-
directed mutagenesis to identify disruption of these effects (Wang and Wang 2003).  
These compounds include tetrodotoxin (TTX), conotoxins, scorpion toxins (α and β), 
DDT, and a wide variety of antiarrhythmic, antidepressant and local anaesthetic drugs.  
While not all of these compounds target hH1 (e.g. antidepressants target neural isoforms), 
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many are thought to bind at similar sites across different isoforms in the sodium channel 
family.  This results in cross-reactivity by drugs which act to modulate sodium channel 
function; cardiac drugs can have severe neurological side effects, for example.  Interest-
ingly, many of these compounds target the S6 segments of some or all of the domains, 
possibly indicating that the effects stem from interference with sodium permeation or 
channel gating (Wang and Wang 2003). 
 
 
Figure 1.4:  Sites of interaction between hH1 and its known binding partners.  Phos-
phorylation sites in the I-II linker are also indicated, as is the fast-inactivation gate 
(“IFM”) in the III-IV linker.  From left to right, “Ank” indicates the ankyrin G interaction 
site.  “EFh” indicates the putative EF-hand in hH1.  “FHF” indicates the FHF1b interac-
tion site.  “CaM” represents the IQ-motif calmodulin interaction site.  “Ubq” indicates a 
ubiquitination site, mediated by the Nedd4-like E3 ligase.  “PDZ” indicates the syntro-
phin interaction site.  Each of these features are described in more detail in the accompa-
nying text.  Adapted from Abriel and Kass 2005. 
 
 
 As mentioned, drugs that target ion channels are both powerful and dangerous.  
Most of these compounds have significant dose-dependent effects which can result, para-
doxically, in fatal responses.  For example, Class I anti-arrhythmic drugs such as 
quinidine (I-A), lidocaine (I-B), and encainide (I-C) slow cardiac conduction by blocking 
hH1.  While these drugs were initially hailed by the medical community, it has since been 
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shown that use of these drugs to suppress arrhythmias may actually cause an increase in 
mortality, as a result of proarrhythmic side effects of these compounds.  In other words, 
the drugs can actually cause the effect that they were administered to prevent! 
 A better mechanistic understanding of channel and drug behavior will hopefully 
lead to better compounds for the treatment of arrhythmias.  Some of the mechanics are 
already understood.  For example, many of the current generation of antiarrhythmics act 
in a “use-dependent” manner, i.e. these drugs bind only when the channel is in the open 
state, and therefore act in a cumulative manner over time even at steady-state drug con-
centrations.  Further mechanistic insights will require better understanding of both (a) the 
molecular mechanisms of single channel behavior and (b) how alterations to single chan-
nel behavior translate to organ-level changes in function. 
 
hH1 interacts with many proteins 
 In addition to interactions with many drugs and toxins, the channel interacts with 
a large number of cellular proteins.  As mentioned earlier, the channel itself has a beta 
subunit, of which there are four isoforms (β1-β4).  All are expressed in the heart.  The 
role of the beta subunits is to fine-tune channel function.  Further details will not be dis-
cussed here, as all of the gating and pore machinery necessary for voltage-gated sodium 
ion flux can be found in the α subunit, which is the focus of this dissertation.  Other pro-
teins that interact with hH1 are indicated in Figure 1.4 (Abriel and Kass 2005).  Many of 
these binding partners have only been identified in the past few years, as new information 
and new tools accelerate the pace of research.  In some cases, the functional relevance of 
the interacting protein has yet to be identified.  Current information suggests that five 
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proteins interact with hH1: ankyrin-G, syntrophins, Nedd4-like E3 ubiquitin ligases, fi-
broblast growth factor homologous factor 1b (FHF1b), and calmodulin (Abriel and Kass 
2005). 
Ankyrins 
Ankyrins are cytoskeletal adapter proteins that play an important role in anchor-
ing membrane proteins and possibly in trafficking/targeting as well.  Of the three mam-
malian isoforms (ankyrin-B, ankyrin -G, and ankyrin –R), only ankyrin-G has been 
shown to directly interact with hH1.  This interaction is mediated by the nonapeptide se-
quence VPIAVAESD in the II-III linker, encompassing residues 1047-1055 (Lemaillet et 
al. 2003).  As will be discussed later in this Chapter, a number of disease causing muta-
tions occur in hH1, one of which occurs in this site.  The mutation E1053K (highlighted 
in red in the nonapeptide; see also Figure 1.5) causes Brugada syndrome.  This mutation 
has been shown to abolish interactions between ankyrin-G and hH1 and disrupt normal 
channel trafficking (Mohler et al. 2004). 
Syntrophins 
 The syntrophin family of proteins are also adapter proteins, functioning to localize 
a number of protein targets to the muscle protein dystrophin.  There are five known iso-
forms (α1, β1, β2, γ1, γ2) which are coded for on separate genes and exhibit tissue-
specific expression (Albrecht and Froehner 2002).  Interaction with protein targets is me-
diated through a PDZ domain (“postsynaptic density-95/discs large/zona occludens-1”), 
which binds to PDZ binding motifs.  The consensus PDZ binding motif consists of the C-
terminal tripeptide –SIV-COOH, found in a wide variety of proteins including protein 
kinases and membrane proteins.  This motif is found in hH1 (NaV1.5).  One other mem-
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ber of the human sodium channel family, NaV1.4, has a slightly modified PDZ binding 
motif (–SLV-COOH).  None of the other family members have similar sequences.  Both 
hH1 and NaV1.4 have been shown to bind syntrophins and can be copurified in complex 
with syntrophin and dystrophin (Gee et al. 1998).  The specific syntrophin isoforms that 
are involved in the interaction have not been fully characterized.  However, the γ2 iso-
form has been specifically shown to interact with hH1, and both are co-expressed in in-
testinal smooth muscle cells (Ou et al. 2003).  Likewise, the functional importance of this 
interaction has not yet been pinned down; various studies have come to different conclu-
sions about the electrophysiological effects of this interaction (Zhou et al. 2002; Ou et al. 
2003). 
Nedd4-like E3 ubiquitin ligase 
 hH1 is ubiquitinated in vivo to regulate membrane turnover of the protein (van 
Bemmelen et al. 2004).  Ubiquitin is a 7 kDa protein found in all animal cells; this pro-
tein is covalently attached to a wide variety of cytoplasmic and membrane proteins 
(“ubiquitination”).  This process can regulate trafficking and internalization, and can also 
tag a protein for lysosomal or proteasomal degradation. 
 Ubiquitination, reviewed elsewhere (Vander kooi 2004), is carried out in a cas-
cade of transfer reactions involving, sequentially, E1, E2 and E3 ubiquitin ligases.  These 
reactions activate ubiquitin for attachment to target proteins.  The attachment of ubiquitin 
occurs via a covalent bond between its highly conserved C-terminal glycine and a lysine 
on the target protein.  Ubiquitin is first recruited by and attached via a thioester bond to 
the E1 ligase in an ATP-dependent reaction.  The molecule is then transferred to an E2 
ligase, also via thioester linkage, for presentation to the target protein, which is bound to 
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E3 ligase.  The activated ubiquitin may be transferred directly to the E3 ligase or posi-
tioned by the E3 ligase to bring the E2-ubiquitin complex into close proximity with the 
target.  Either way, E3 ligases play a critical role in positioning the activated ubiquitin 
and the target.  The relative roles played by E1, E2 and E3 ligases are reflected in number 
of isoforms of each found in animals; most organisms contain only one E1 ligase, a few 
E2 ligases, but hundreds of E3 ligases. 
 The Nedd4-like family of E3 ligases have two to four WW domains that interact 
with the consensus sequence PPxY (PY motif) on its substrates (Staub et al. 1996).  
These PY motifs are found in the C-termini of almost all voltage gated sodium channels, 
including hH1 (Abriel and Kass 2005).  The human Nedd4-2 E3 ligase has been shown to 
directly bind the hH1 PY motif and ubiquitinate the channel in mammalian cells (van 
Bemmelen et al. 2004).  Furthmore, ubiquitinated hH1 has been detected in cardiac tis-
sue, and the presence of Nedd4-2 in HEK293 cells increases the rate of internalization of 
coexpressed hH1 likely as a result of ubiquitination (Rougier et al. 2005).  With nine 
Nedd4-like isoforms, five of which have been demonstrated to be expressed in the heart, 
it is likely that this is a physiologically relevant mechanism of channel regulation. 
Fibroblast growth factor homologous factor 1b (FHF1b) 
FHF1b is a recently discovered member of the fibroblast growth factor family that 
is expressed in the cytoplasm and is not secreted (Liu et al. 2001).  The crystal structure 
of this protein has been recently determined and, as expected, showed high structural 
homology to other members of the fibroblast growth factor family (Olsen et al. 2003).  
Key sequence differences, however, prevent it from being secreted (Liu et al. 2001).  Re-
cent studies have shown that the protein interacts with the C-terminal cytoplasmic do-
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mains of hH1 and other voltage-gated sodium channels (Liu et al. 2001; Liu et al. 2003).  
These studies have also shown that coexpression of FHF1b with hH1 results in changes 
to steady state inactivation.  Though the functional role of FHF1b in modulation of hH1 
has been characterized (Liu et al. 2003), the molecular details have yet to be explored. 
Calmodulin (CaM) 
Calmodulin is a ubiquitous calcium sensor protein, mediating the calcium-
dependent regulation of a large number of cellular proteins.  These include regulation of 
brush border myosin I heavy chain, calcium/calmodulin dependent kinase II, phosphati-
dyl-inositol-3 kinase, and nicotinamide dinucleotide kinase (Nelson and Chazin 2005).  It 
is highly conserved from bacteria to mammals, and is 148 residues long in most higher 
organisms including humans.  The protein consists of two domains connected by a flexi-
ble linker.  Each domain contains a pair of EF-hands, the calcium-sensing elements of the 
protein.  EF-hands are discussed in detail later in this Chapter. 
Calmodulin binds to hH1 in the C-terminal cytoplasmic domain in the region 
R1897-S1925 via an IQ-motif.  The IQ motif is a common calmodulin binding motif first 
identified in neuromodulin (Alexander et al. 1988) and first characterized in myosins 
(Cheney and Mooseker 1992).  The consensus sequence of the IQ motif is 
δQxxxβGxxxβxxδ, where δ represents any of Phe/Ile/Leu/Val and β represents either 
Lys or Arg (Bahler and Rhoads 2002).  The Gly at position 7 is only loosely conserved, 
as is the final hydrophobic residue.  These relaxed requirements are reflected in the defi-
nition of an “IQ-like” motif with the consensus sequence δQxxxβxxxxx (Bahler and 
Rhoads 2002).  In most cases, the IQ motif is able to bind apo (Ca2+-free) calmodulin and 
binding of calcium to calmodulin either maintains or weakens this interaction.  It is 
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commonly held that the function of the IQ motif is to localize calmodulin at basal cal-
cium levels, so that the local concentration is high near a site where calmodulin is to per-
form a calcium-dependent role.  This interaction between CaM and hH1 is one of the fo-
cuses of this dissertation; further details can be found in Chapter IV. 
 
Mutations in hH1 lead to arrhythmogenic disease syndromes 
 A large number of arrythmogenic mutations have been identified in hH1, as 
shown in Figure 1.5 (Balser 2001).  Most commonly, these mutations lead to long QT 
syndrome subtype 3 (LQT3) or Brugada syndrome (BrS).  These genetic diseases are of-
ten insidious in their presentation, silent until they result in sudden collapse or death.  For 
example, patients with Brugada syndrome commonly die in their sleep, secondary to ven-
tricular fibrillation. 
 
 
Figure 1.5:  Arrhythmogenic mutations in hH1 can be found throughout the protein.  
Adapted from Balser 2001. 
 
 
 Most of these mutations have a definite electrophysiological profile, and the dys-
functional aspects of individual channel behavior can be modeled to explain the macro-
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scopic problems linked to these mutations.  In LQT3, reopening of inactivated sodium 
channels results in prolonged ventricular repolarization (Li et al. 2000; Kass and Moss 
2003).  This manifests as a lengthening of the Q-T interval in an EKG.  Resting QTcorrected 
> 460 milliseconds is diagnostic of long QT syndrome, as compared with control QTcor-
rected of 436 ± 19 ms (Ackerman et al. 2002).  The lengthened Q-T interval substantially 
raises the risk of arrhythmias, though the mechanisms behind this risk remain unclear.  In 
Brugada, on the other hand, the sodium current density is lower (Naccarelli et al. 2002).  
Thus, some areas may not depolarize (“fire” an action potential) at all, also raising the 
risk of arrhythmias.  This leads to an increased risk of so-called “reentrant” arrhythmias 
caused by regions which, after failing to fire with the rest of the heart tissue, fire inappro-
priately during mid-cycle.  Thus, both gain of function and loss of function mutations are 
arrhythmogenic – revealing the fine-tuned nature of this system.  
Two mutations which have stubbornly defied electrophysiological character-
ization are the D1790G and 1795insD mutations.  Both of these mutations occur in the 
proximal part of the C-terminal cytoplasmic tail, as indicated in Figure 1.5. 
 Analysis of the hH1 amino acid sequence has been performed in an attempt to de-
termine the nature of the disruptions caused by these disease-associated mutations.  As 
will be detailed in Chapter II, a putative consensus EF-hand calcium binding loop was 
identified in the twelve residue stretch D1788-E1799.  This led to the hypothesis that the 
proximal part of the hH1 C-terminus contains a functional EF-hand domain, and that dis-
ruption of the EF-hand by D1790G and 1795insD is able to cause changes in the electro-
physiological behavior of the channel.  This was an exciting idea, because calcium-
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dependent regulation of voltage-gated sodium channels had not been observed previ-
ously. 
 
The EF-hand is a ubiquitous calcium-binding motif 
 
EF-hands are found in a diverse set of calcium sensors and modulators 
Since a significant portion of the experiments in this dissertation involve the hH1 
EF-hand directly or tangentially, it is important to understand the nature and role of EF-
hands in normal physiology.  The EF-hand is a very common calcium binding motif; over 
1000 have been identified in animal genomes from their unique sequence signatures 
(Henikoff et al. 1997).  Calcium levels are known to regulate many processes in biology 
(Berridge 1997), including excitation-contraction coupling in heart and skeletal muscle 
(Celio et al. 1996).  The intracellular concentration of calcium is tightly regulated, with a 
low basal concentration of approximately ~100 nM (Braveny 2002), and release of cal-
cium from intracellular stores during a signaling event can result in intracellular calcium 
concentrations as high as 10 µM, and local concentrations in subcellular compartments 
may be orders of magnitude higher than this.  The EF-hand motif is a structural element 
of proteins used to transduce changes in calcium concentration into a biochemical signal.  
 
Acidic residues in the EF-hand loop are critical for calcium-chelation 
 
 Structurally, the EF-hand is a helix-loop-helix motif first identified in parvalbu-
min (Kretsinger and Nockolds 1973).  The “EF” refers to the two helices in the motif.  It 
is called a “hand” because, if thumb and index finger are used to form an “L” shape and 
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the other three fingers curled inward so the fingertips touch the palm, the two extended 
fingers approximately represent the helices of the motif and the curled fingers together 
with the palm approximately represent the calcium binding loop.  The angle between 
thumb and index finger, representing the interhelical angle, can be variable; calcium 
binding can cause changes in this interhelical angle, resulting in widespread conforma-
tional changes which can then transduce the calcium signal into a biochemical event by 
altering the binding surface presented by the protein. 
   
 
 
Figure 1.6:  EF-hand calcium binding loop coordinates the calcium (II) ion with pen-
tagonal bipyramidal geometry.  (a) Consensus EF-hand calcium binding loop sequence.  
Residues 1, 3, 5, 7, and 12, indicated in red, contribute oxygens for calcium coordination; 
see text for details.  Position 6 Gly is strongly conserved for steric/conformational rea-
sons.  Position 9, shown in blue, participates in coordination by hydrogen bonding with a 
water molecule needed to complete the coordination sphere.  (b) Pentagonal bipyramidal 
geometry of calcium coordination in an EF-hand.  All of the peripheral large spheres 
(black and blue) represent oxygen atoms participating in coordination. 
 
 
 
The consensus loop of the EF-hand is comprised of twelve residues (Figure 1.6a) 
that surround the bound calcium (II) ion, coordinating the ion with oxygen atoms ar-
ranged in a pentagonal bipyramidal geometry (Drake et al. 1997; Yang et al. 2002), as 
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shown in Figure 1.6b.  The side chains of residues at positions 1, 3, and 5 each provide 
one oxygen ligand, thus Asn, Asp, Gln, or Glu are most frequently found at these posi-
tions.  The main chain oxygen of residue 7 provides a fourth ligand.  In order to attain 
appropriate positioning of residues 5 and 7, the residue in position 6 must occupy an un-
usual backbone conformation favorable only for glycine, resulting in strong conservation 
of Gly in this position.  The Glu residue at position 12 is strictly conserved because it 
provides two coordination sites for a critical bidentate ligand.  Residue 9 is also involved 
in coordinating the calcium ion by hydrogen bonding the water molecule that chelates the 
ion, completing the coordination sphere. 
Given the complexity of the calcium coordination geometry, it seems likely that if 
an EF-hand calcium binding domain is present in hH1, mutations in and around the cal-
cium binding loop may well perturb its calcium binding activity.  Indeed, the D1790G 
mutant associated with long QT subtype 3 removes the oxygen atom used for calcium 
coordination at position 3.  Such a mutation is predicted to reduce calcium affinity by an 
order of magnitude or more.  The 1795insD Brugada mutation would likewise shift the 
register of at least one ligand, and is anticipated to reduce or abolish calcium binding 
function.   
Given the available evidence for the presence of an EF-hand domain in hH1, we 
set out to test whether there is biophysical or electrophysiological evidence of calcium 
binding to hH1, and if mutations in the calcium binding loop could diminish or abolish 
calcium-dependent properties of the channel that were found.  These findings are dis-
cussed in Chapter II.  Chapter III discusses work that was done to characterize the precise 
residues in the C-terminus that are involved in calcium binding and to refine our under-
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standing of this EF-hand domain, which has both canonical and unique aspects to its se-
quence signature.  That chapter describes the surprising result that the folded EF-hand 
core has a substantially lower calcium affinity than a construct containing both the EF-
hand and the downstream IQ motif.  This leads to the work described in Chapter IV, 
which describes characterization of the IQ motif and exploration of cross-talk between 
the two calcium sensing pathways.  Chapter V describes a model based on this data and, 
in addition, takes a broad view of the literature to examine the role of calcium in the regu-
lation of ion channels.  Chapter VI discusses the further implications of this work, pre-
liminary data, and future directions. 
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CHAPTER II 
 
AN EF-HAND IN THE SODIUM CHANNEL COUPLES INTRACELLULAR 
CALCIUM TO CARDIAC EXCITABILITY 
 
 
Introduction 
 As discussed in Chapter I, life-threatening arrhythmias have been demonstrated to 
arise from inherited Na+ channel dysfunction (Bennett et al. 1995; Chen et al. 1998).  
Mutations throughout hH1 have been implicated in arrhythmia syndromes; a number of 
these reside within the C-terminal cytoplasmic domain.  These mutations alter functional 
properties of channel gating (Dumaine et al. 1996; Wang et al. 1996; Benhorin et al. 
1998; Bezzina et al. 1999).  One of these mutations, D1790G, has been associated with 
long QT syndrome subtype 3 (An et al. 1998; Wehrens et al. 2000).  Analysis of the hH1 
C-terminus revealed an ordered, helical domain (Cormier et al. 2002a), but localization of 
structural and functional components of channel gating has proven difficult. 
 This chapter reports a series of studies, conducted in collaboration with Dr. 
Tammy Wingo and Dr. Jeff Balser and previously published (Wingo et al. 2004).  These 
studies identified the structural motif underlying D1790G-mediated LQT3.  To accom-
plish this goal, we made use of computational methods, patch-clamp electrophysiology, 
and a variety of spectroscopic tools.  These approaches uncovered the presence of an in-
trinsic EF-hand calcium binding site in the polypeptide chain of the hH1 α subunit, spe-
cifically in the C-terminal domain.  D1790G perturbs normal calcium binding to this mo-
tif and alters calcium-dependent functional properties of the channel.  This intrinsic cal-
cium binding site is just upstream of a calmodulin binding site, an interesting coincidence 
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which will be explored in later chapters.  In addition to examining the molecular patho-
physiology associated with D1790G, these results provide an improved understanding of 
the functional role of the Na+ channel C-terminus in cardiac rhythm and add to our un-
derstanding of the role of Ca2+ in cellular regulation. 
 
Results 
 
hH1 contains a putative EF-hand in the C-terminal cytoplasmic domain 
Analysis of the hH1 C-terminus using the NCBI PSI-BLAST program (Altschul 
et al. 1990; Altschul et al. 1997), Figure 2.1a, revealed homology to EF-hand helix-loop-
helix motifs in a number of Ca2+-binding proteins, such as calmodulin.  As discussed in 
Chapter I, EF-hand proteins mediate the transduction of Ca2+ signals in cellular re-
sponses, including regulation of ion channels (Peterson et al. 2000).  Remarkably, the EF-
hand was found approximately 120 residues upstream from an “IQ-domain” calmodulin 
binding site identified previously, in the region I1908-R1919 (Deschenes et al. 2002b; 
Tan et al. 2002a).  A structure-based multiple sequence alignment with several of the 
highest scoring hits from the PSI-BLAST search, all proteins with EF-hands whose 3D 
structures are known (1C07, 1C7V, 1EXR, 1BJF, 1TRF; Figure 2.1a), provided further 
support for this structural class assignment. 
A single EF-hand motif is not an intrinsically stable structure, and is always found 
at least in pairs (Shaw et al. 1990; Lewit-Bentley and Rety 2000).  A pair of EF-hands 
forms the minimal stable structural unit—a four-helix bundle (Strynadka and James 
1989; Linse and Forsen 1995).  According to our multiple sequence alignments, the hH1 
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C-terminus has a pair of EF-hands in the region E1773-D1852.  A Ca2+ binding site is 
found in the first EF-hand sequence, based on the close fit to the consensus binding loop 
(cyan box, Figure 2.1a).  
 
 
Figure 2.1: Structure based sequence alignment and model of the proximal region of the hH1 C-terminus 
(residues 1773-1852).  This region was aligned with Ca2+-binding proteins identified using PSI-BLAST 
(PDB identifiers indicated at left; see text).  (a) Bolded blocked regions indicate key residues responsible 
for Ca2+ ion coordination (designated as positions 1, 3, 5, 12) in EF-hand loops.  The cyan box identifies an 
EF-hand predicted to have a strong Ca2+ binding site; the orange box identifies a second EF hand that could 
serve to stabilize the requisite paired structure.  (b) Energy-minimized model of the hH1 C-terminus 
(green) superimposed on the backbone structure of the Ca2+-binding proteins used as templates in model 
construction (red).  (c) Predicted model for the hH1 proximal C-terminus highlighting features of the EF-
hand loop.  The functional EF-hand loop is shown in yellow, and the distal putative loop in orange.  Key 
residues are color-coded for clarity and shown in ball-and-stick representation.  The residue highlighted in 
red represents residue D1790, which is in position 3 for Ca2+ ion coordination.  Mutation of this residue 
(D1790G) results in long QT syndrome.  Other residues important for Ca2+ ion coordination (position1: 
E1788, position 5: D1792, position 12: E1799) are highlighted in white.  Additional positions where muta-
tions elicit arrhythmia phenotypes (e.g. E1784; see text) are indicated in green. A translucent cyan sphere 
represents bound Ca2+ ion.  Model constructed by Tammy Wingo.  Taken from Wingo et al 2004. 
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The second EF-hand loop is not expected to bind Ca2+ because it lacks key con-
sensus side chains involved in chelating the ion.  The lack of a competent Ca2+ site in the 
second EF hand (orange box, Figure 2.1a) is not atypical, and binding of a single Ca2+ ion 
is known to be sufficient to activate several EF-hand Ca2+ sensor domains.  Examples of 
the latter include the N-terminal domain of cardiac troponin C and the C-terminal domain 
of centrin. 
Threading calculations for hH1 (1773-1852) against a library of all structurally 
characterized tertiary fold templates confirmed that a paired EF-hand motif is a highly 
plausible 3D structure for this sequence.  A structural model (Figure 2.1b,c) was therefore 
constructed using a structure-based sequence alignment with the five EF-hand protein 
templates listed in Figure 2.1a.  The presence of an ordered structure is consistent with 
prior work showing the C-terminus contains helical secondary structure (Cormier et al. 
2002a). 
 
hH1 exhibits Ca2+-dependent changes in voltage-dependent availability 
Like most voltage-gated ion channels, hH1 can occupy an open (Na+ conducting) 
state, as well as two distinctive non-conducting states, termed “closed” and “inactivated”. 
These states are discussed in detail in Chapter I.  Briefly, channels in the closed state can 
open and generate Na+ current (INa) in response to a stimulus, whereas channels in the 
inactivated state cannot open and are functionally unavailable.  Under resting conditions, 
the potential across the membrane determines the ratio of closed to inactivated channels 
in a population of Na+ channels.  Depolarization of the membrane potential, i.e. potentials 
that are closer to 0 mV, shifts the balance to favor the inactivated state. Because this 
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“availability curve” is steepest at voltages that approach the cardiac myocyte maximum 
diastolic membrane potential (resting membrane potential Vrest ~ –90 mV), the population 
of Na+ channels available to open is sensitive to even modest changes in Vrest.  Pathologic 
conditions which alter Vrest can markedly change hH1 availability, modifying INa and de-
stabilizing the cardiac rhythm (Shaw and Rudy 1997).  Ischemia and acidosis are condi-
tions which have been previously described to alter Vrest.   
The potential for a functional EF-hand domain in hH1 led us to investigate the ef-
fects of intracellular Ca2+ on the voltage-dependence of Na+ channel availability (Figure 
2.2).  These studies were conducted by Tammy Wingo working under the mentorship of 
Dr. Jeffrey Balser.  For these studies, whole-cell Na+ currents (INa, see top inset, Figure 
2.2), were recorded in voltage-clamped tsA201 cells transiently transfected with wild 
type (WT) hH1 cDNA.  Voltage-dependent channel availability was assessed by quanti-
fying the INa magnitude during an activating pulse to –20 mV (see bottom inset, Figure 
2.2a) as a function of various “test” resting membrane voltages.  Figure 2.2a indicates 
that raising free Ca2+ concentrations from 0 to 10 µM caused a rightward shift in avail-
ability, with the effect saturating at ~1 µM.  The observed change is consistent with a de-
stabilizing effect on inactivation gating: the membrane potential at which 50% of the Na+ 
channels were available to open (V1/2) was –98.3 ± 1.5 mV in Ca2+-free conditions, but 
was –87.2 ± 1.0 mV in 1 or 10 µM Ca2+ (p < 0.001). A dose-response curve fitted to the 
V1/2 data (Figure 2.2c) yields an EC50 of 175 nM, a value consistent with a physiological 
and structural role for Ca2+-binding to the EF-hand (Linse and Forsen 1995). Other gating 
processes, including activation and recovery from inactivation, were evaluated as de-
scribed previously (Veldkamp et al. 2000), and did not respond to added Ca+2. 
31 
Although studies have identified effects of the Ca2+-dependent cofactor 
calmodulin on Na+ channel gating (Deschenes et al. 2002b; Tan et al. 2002a), direct ef-
fects of Ca2+ on Na+ channel availability have not been described. However, an important 
change in the present studies was to utilize BAPTA as a Ca2+ buffer in the patch electrode 
solution.  Over the range of free Ca2+ concentrations tested (0 to 10 µM), the V1/2 values 
for the hH1 availability curve (–87 to –98 mV) bracket the value obtained in prior studies 
using 10 mM EGTA and no added Ca2+ (–93.5 mV) (Deschenes et al. 2002b; Tan et al. 
2002a).  In fact, the V1/2 of the availability curve in nominally Ca2+ free solutions contain-
ing EGTA is quite close to the V1/2 measured at the EC50 Ca2+ concentration when 
BAPTA is used, suggesting EGTA is not as effective as BAPTA in maintaining Ca2+ at 
low (nM) levels. Hence, with EGTA as the calcium buffer, detection of Ca2+ effects on 
Na+ channel availability would be difficult, since the V1/2 dynamic range would be no 
greater than 5 mV (from –93 to –98 mV). Overall, our findings suggest that the selection 
of metal ion buffer is critical when evaluating the function of the hH1 EF-hand in cellular 
preparations. 
In prior work describing Ca2+-CaM mediated effects on Na+ channel inactivation, 
we and others have noted changes in the rate of fast Na+ current decay that appear to be 
mediated by Ca2+ (Deschenes et al. 2002b; Tan et al. 2002a).  However, with BAPTA 
substituted for EGTA, we find the hH1 INa decay rate (Figure 2.2a, inset) does not change 
appreciably with added Ca2+ (fitted INa decay time constants provided in Figure 2.2, leg-
end).  Recognizing that BAPTA provides more stringent Ca2+ buffering conditions, and 
more rapid Ca2+ binding kinetics (Tsien 1980), we speculate that the small Ca2+-
dependent effect previously noted on hH1 INa decay (Tan et al. 2002a)  may result from 
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activation of Ca2+-signalling pathways that modulate hH1, but are less tightly controlled 
by EGTA than BAPTA. 
 
 
Figure 2.2: Inactivation gating of wild-type hH1 channels is Ca2+ sensitive.  (a) Solid lines indicate a least-
squares fit of a Boltzmann function to the data.  The membrane potential of 50% channel availability (V1/2) 
was: –98.3 ± 1.5 (n=11), -95.4 ± 0.8 (n=4), -92.8 ± 1.1 (n=8, p < 0.05), -91.6 ± 0.9 (n=8, p < 0.01), -87.8 ± 
1.6 (n=7, p < 0.001), and –87.1 ± 1.0 mV (n=17, p < 0.0001) for 0, 100, 150, 250 nM, 1 µM, and 10 µM 
Ca2+, respectively.  Slope (k) factor in zero free Ca2+ decreased slightly in 10 µM Ca2+: 6.38 ± 0.24 (n=11) 
versus 5.54 ± 0.23 (n=17), respectively (p < 0.05).  (a, inset) Representative INa measured at –20 mV after 
holding at –120 mV in 0 and 10 µM free Ca2+ reveals no appreciable change in current magnitude or inacti-
vation kinetics.  (b) Voltage-dependence of inactivation dose response analysis with CaM inhibitory pep-
tide 290-309, as above.  V1/2 values: -97.6 ± 1.9 (n=4), -93.7 ± 1.8 (n=4), -90.5 ± 0.7 (n=4, p < 0.05), -91.6 
± 0.9 (n=4, p < 0.05), -87.3 ± 1.0 (n=3, p < 0.01), -85.3 ± 0.8 (n=6, p < 0.001).  Significant differences in-
dicate comparisons to the 0 Ca2+ condition.  (c) Dose-response analysis of data represented in panels (a) 
and (b).  EC50 values, with and without the CaM inhibitory peptide 290-309, were 175 and 199 nM respec-
tively.  Work done by Tammy Wingo.  Taken from Wingo et al 2004. 
 
 
 
33 
The hH1 C-terminal domain contains a structured domain 
 
 To assess whether the consensus EF-hand motif is capable of binding Ca2+, we 
characterized a bacterially expressed construct containing the first 148 residues of the C-
terminal region (hH1-CTD-148).  Circular dichroism (CD) was used to examine secon-
dary structure, nuclear magnetic resonance (NMR) to probe tertiary structure, and fluo-
rescence spectroscopy to directly monitor the binding of Ca2+.  The profile of the CD 
spectrum of hH1-CTD-148 has the characteristic minimum at 222 nm indicative of sig-
nificant helical content (Figure 2.3a).  NMR signals are relatively narrow and are widely 
dispersed across the NMR spectrum, particularly in the 1H dimension (Figure 2.3b, Fig-
ure 2.4a).  The dispersion of 1H signals from 6.5-11.5 p.p.m. in the 2D 15N-1H HSQC 
NMR spectrum of Ca2+-loaded hH1-CTD-148 is clear evidence of a well-folded struc-
tural domain.  
 
 
 
 
Figure 2.3: hH1-CTD-148 is a well-folded helical protein.  (a) CD and (b) 15N-1H HSQC NMR spectra of 
hH1-CTD-148.   
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The hH1 C-terminal domain has µM calcium affinity   
 Trp1798 in position 11 of the first EF-hand loop (Figure 2.1) serves as a conven-
ient fluorescent probe to monitor Ca2+ binding since this is the only tryptophan in hH1-
CTD-148.  A significant (~20%) quenching of fluorescence accompanied by a small blue 
shift in the spectrum is observed upon addition of Ca2+ to the protein (Figure 2.4b).  Fit-
ting a plot of fluorescence intensity versus Ca2+ concentration (Figure 2.4c) provides an 
estimate of the Ca2+ dissociation constant (Kd) of 1.3 µΜ, within the range expected for a 
Ca2+ sensor domain in vitro (Linse and Forsen 1995). 
 
D1790G disrupts calcium-dependent properties of hH1 
The LQT3 mutation D1790G resides at a position where the native aspartic acid 
side chain directly coordinates Ca2+ in consensus EF-hand loops (position 3; Figure 2.1a). 
Based on extensive prior mutational analysis on EF-hand proteins (Linse and Forsen 
1995), the D1790G mutation would be predicted to reduce Ca2+ affinity approximately 
one order of magnitude.  Such an effect could conceivably alter inactivation gating in 
hH1, and at least partly explain the LQT phenotype (Wehrens et al. 2000). 
As predicted, D1790G significantly impairs the inactivation-destabilizing effect 
of Ca2+ on hH1 (Figure 2.4d).  In D1790G, 10 µM Ca2+ only shifts the V1/2 positively by 
6.1 mV, versus 11.1 mV in WT (p < 0.0001 vs. D1790G, see Figure 2.2 and 2.4 legends 
for absolute V1/2 values). The availability curves for D1790G and WT in 0 Ca2+ did not 
differ significantly, suggesting the mutation does not cause an allosteric effect on channel 
structure.  However, in nearly all non-zero Ca2+ concentrations, the voltage-dependent 
availability of the mutant is left-shifted (hyperpolarized) relative to WT (Figure 2.4d), as 
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noted previously in studies employing less stringent Ca2+-buffering conditions, but utiliz-
ing β1 subunit coexpression (An et al. 1998; Wehrens et al. 2000).  Here we find that un-
der more tightly-controlled Ca2+ buffering conditions, co-expression of β1 is not required 
to identify a hyperpolarizing shift in D1790G availability relative to WT. 
 
 
 
Figure 2.4: Structural characterization and calcium binding to hH1-CTD-148.  (a) Close-up view of the 
down-field shifted region of hH1-CTD-148 wild type spectrum acquired at 28 ºC (dashed contours) with 
the corresponding region of the spectrum acquired under identical conditions for the D1790G mutant (solid 
contours).  (b) Calcium dependence of the intrinsic tryptophan fluorescence spectrum of hH1-CTD-148 
wild type, and the D1790G and 4X mutants.  See legend.  Filled symbols are for the apo state and open 
symbols for a solution containing ~20 µM Ca2+.  (c) Plot of fluorescence intensity versus added Ca2+ for 
hH1-CTD-148 (solid line) and the D1790G mutant (dotted line).  The line through the points is the best fit 
to a single-site standard binding curve.  Since the binding to the mutant is incomplete in the main panel, an 
inset is included to show the full binding curve (to 600-fold excess).  (d) Voltage dependence of availability 
for D1790G and the 4X mutant.  For reference, the wild type data is also included.  For D1790G, the V1/2 
was -101.9 ± 1.7 (n=4) and –95.8 ± 1.0 mV (n=7) for 0 Ca2+ and 10 µM Ca2+ respectively (p < 0.01).  k 
values were: 7.55 ± 0.14 (n= 4) and 5.68 ± 0.219 (n = 7) for 0 Ca2+ and 10M Ca2+, respectively (p < 
0.001).  For 4X, V1/2 were  -101.3 ± 2.2 mV in 0 Ca2+ (n = 9) and -101.1 ± 1.1 in 10 µM Ca2+ (n = 9) (p = 
N.S.).  k values were: 7.58 ± 0.43 (n= 9) and 6.28 ± 0.276 (n = 9) for 0 Ca2+ and 10 µM Ca2+, respectively 
(p < 0.01).  Electrophysiological work in panel d done by Tammy Wingo.  Taken from Wingo et al 2004. 
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The impact of a hyperpolarizing shift in availability due to D1790G has been 
mathematically modeled in detail (An et al. 1998; Wehrens et al. 2000).  The reduced 
availability of Na+ channels at the resting membrane potential leads to a diminished Na+ 
current during the initiation of the action potential, which triggers a cascade of changes in 
the kinetics of multiple ionic currents during the action potential. This prolongs the car-
diac action potential, increasing the likelihood of cardiac arrhythmias as seen in LQT3 
(An et al. 1998; Wehrens et al. 2000).  A recent study of D1790G has also detected a 
PKA-sensitive increase in sustained, “bursting” Na+ channel activity during sustained 
depolarization (Tateyama et al. 2003), a gating behavior that also provokes LQT3 
(Bennett et al. 1995; Chen et al. 1998).  In our studies, addition of 10 µM intracellular 
Ca2+ did not increase the magnitude of the plateau current in either the wild-type (0.24 ± 
0.14%, n = 11, plateau current relative to peak inward current) or D1790G (0.24 ± 
0.057%, n = 7).  Hence, we postulate that D1790G evokes LQT3 by prolonging the car-
diac action potential through two complementary mechanisms: 1) a protein kinase A-
dependent, Ca2+-independent increase in channel bursting that increases the plateau cur-
rent (Tateyama et al. 2003), and 2) disruption of Ca2+-binding in the hH1 EF-hand, caus-
ing a hyperpolarizing shift in hH1 voltage-dependent availability (Figure 2.4d). 
Biophysical analysis of hH1-CTD-148 containing the D1790G mutation reveals 
that the mutation does not cause significant changes to the NMR and CD spectra of the 
domain.  Superimposing the down-field region of the 2D 15N-1H HSQC NMR spectra to 
compare the mutant and WT proteins provides convincing evidence that the mutation 
does not alter the protein structure (Figure 2.4a).  In contrast, measurements of trypto-
phan fluorescence reveal Ca2+ binds more weakly to the mutant (Figure 2.4b,c) with a Kd 
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of 27 µΜ,  ~20-fold lower than hH1-CTD-148.  This reduction in affinity is consistent 
with the effects of mutations in other EF-hand Ca2+ binding proteins (Linse and Forsen 
1995) and is sufficient to reduce the ability of the EF-hand domain to act as a Ca2+ sen-
sor.  Together, the patch-clamp and biophysical data suggest that D1790G causes LQT3 
by weakening Ca2+-dependent regulation of hH1 availability.  This weakening is accom-
plished by disruption of Ca2+ binding to the EF-hand. 
 
A “4X” mutant abolishes calcium-dependent properties of hH1 
To further test this hypothesis, a mutant hH1 was designed to completely eradi-
cate Ca2+ binding to the functional EF-hand.  The first EF-hand binding loop contains the 
consensus acidic side chains at positions 1, 3, and 5, and the highly conserved glutamic 
acid at position 12 (Figure 2.1a), all of which directly chelate Ca2+.  The corresponding 
“4X” mutant (E1788A, D1790A, D1792A, E1799A) was prepared and examined electro-
physiologically (whole channel) and in vitro (hH1-CTD-148 construct). 
Raising free Ca2+ from 0 to 10 µM did not change “4X” voltage-dependent avail-
ability (Figure 2.4d).  Moreover, the “4X” availability curve in 0 Ca2+ was similar to WT 
(Figure 2.4d), as was the INa decay rate (Figure 2.4d, inset), suggesting that the quadruple 
substitution does not induce marked structural changes in the C-terminus.  Like WT, the 
“4X” response to Ca2+ was not altered by the CaM inhibitory (290-309) peptide (Figure 
2.4d legend). 
The results from biophysical analysis of hH1-CTD-148 containing the “4X” mu-
tation were fully consistent with the electrophysiological observations.  Ca2+ titrations 
monitored by fluorescence showed almost no response, even at a thousand-fold excess of 
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Ca2+ (Figure 2.4b), indicating that 4X-hH1-CTD-148 does not bind Ca2+ with any detect-
able affinity.  The CD spectrum of 4X-hH1-CTD-148 confirmed the helical structure of 
the wild-type protein was retained.  These results strongly imply that the “4X” mutation 
results in loss of Ca2+ binding activity without loss of overall structure. 
 
Discussion 
 
Ca2+ modulation of ion channels 
Multiple sequence alignment, homology modeling and biophysical data on hH1-
CTD-148 constructs leave virtually no doubt as to the presence of an EF-hand domain in 
hH1 that binds Ca2+ with affinity well within the range of known Ca2+ sensors.  Binding 
of Ca2+ to this EF-hand domain has a role in a critical hH1 gating function: increasing 
channel activity by inducing a depolarizing shift in the voltage-dependence of channel 
availability. 
While the effects of mutations in the EF-hand were consistent between the elec-
trophysiologic and spectroscopic analyses, there was a ~7-fold difference in the apparent 
Ca2+ affinities: the EC50 for the gating effect of Ca2+ on WT channels was 175 nM, while 
the Kd for Ca2+ in the C-terminal fragment binding studies was 1.3 µM. We ascribe these 
differences to the very different contexts under which the measurements were conducted.  
The Kd was measured using a Ca2+ binding domain (hH1-CTD-148) extracted from the 
channel, whereas the EC50 was determined from measuring a voltage-dependent gating 
process in a population of channels within the intact cell.  While the Ca2+ binding event is 
coupled to interactions that lead to changes in the gated state of the channel, the latter 
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(EC50) measurement incorporates factors beyond the Ca2+ affinity alone.  Hence, while 
the absolute values differ, the parallel changes in Ca2+ sensitivity induced by the EF-hand 
mutations lend strong evidence to support the proposal that the Ca2+ effect can be as-
signed to the EF-hand domain in the proximal C-terminus. 
Recent studies (Deschenes et al. 2002b) have described indirect effects of Ca2+ on 
multiple Na+ channel isoforms, through the actions of both CaM and CaM kinase.  Inhibi-
tion of CaM altered both the voltage-dependent availability and the fast current decay of 
skeletal muscle Na+ channels (Deschenes et al. 2002b).  CaM was not observed to have 
this effect on hH1, but was found to inhibit a slowly-inactivating kinetic component 
evoked by sustained depolarization.  Inhibition of CaM kinase was found to slow both the 
rate of current decay and the rate of entry into inactivation, and also induce the voltage-
dependence of hH1 availability; notably, all three effects were found to be independent of 
CaM, and did not extend to the skeletal muscle isoform (Deschenes et al. 2002b).  Simi-
larly, the direct effects of Ca2+ observed on hH1 voltage-dependent availability through 
the EF-hand are CaM-independent: the 290-309 CaM-inhibitory peptide did not diminish 
the Ca2+-dependent effects measured on hH1 availability (Figure 2.2b).  Since 290-309 is 
a highly specific inhibitor of CaM but not CaM kinase, the use of this peptide should not 
confound our results by influencing CaM kinase regulation.  
It remains unclear whether Ca2+ can directly modulate noncardiac Na+ channel 
isoforms through the C-terminal EF-hand. A prior report found that intracellular addition 
of 10 mM BAPTA eliminated the Ca2+-dependent CaM-induced hyperpolarizing shift in 
availability of the skeletal muscle isoform. This finding is not sufficient to exclude the 
possibility that Ca2+ alone may regulate the skeletal muscle isoform; however, given that 
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the Ca2+-dependent CaM effect on the skeletal muscle isoform is directionally opposite to 
the EF-hand mediated effect we observe on the cardiac isoform, direct Ca2+ regulation of 
the EF-hand in skeletal muscle Na+ channels may prove difficult to distinguish because 
the gating effects of Ca2+ in skeletal muscle channels may counterbalance, leading to a 
more subtle net effect. Numerous single amino acid C-terminal sequence changes, both 
within and outside the EF-hand region, are known to significantly influence Na+ channel 
inactivation gating.  These differences could well explain the isoform differences ob-
served in Ca2+-dependent gating effects.  It is increasingly clear that several aspects of 
Na+ channel gating are regulated by intracellular Ca2+, and that mechanisms mediating 
these effects involve both direct (EF-hand mediated) and indirect (CaM (Tan et al. 2002a) 
and CaM kinase (Deschenes et al. 2002b)) actions by Ca2+. 
 
Implications for cardiac arrhythmia syndromes 
Our findings suggest the C-terminal EF-hand domain plays a modulatory role in 
an inherited form of the long QT syndrome (D1790G; Figure 2.4). While the putative loci 
regulating fast and slow inactivation in the Na+ channel were originally localized to the 
domain III-IV linker and P-segments, respectively, additional loci throughout the channel 
were eventually shown to influence both gating processes. Several inherited mutations in 
the hH1 C-terminus are associated with defects in either fast or slow inactivation, and the 
insertion mutant (1795insD) evokes defects in both gating processes, causing both the 
long QT and Brugada syndromes in the same family.  It is noteworthy that both the IQ 
and EF hand motifs in the C-terminus are adjacent to many of these arrhythmia-related 
loci.  As such, it is possible that inherited mutations in the C-terminus may modulate hH1 
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inactivation gating through altering the function of these two, adjacent Ca2+ regulatory 
elements, either separately or in combination. 
The structural model of the EF hand domain (Figure 2.1c) serves as a point of ref-
erence for generating initial hypotheses to unravel molecular mechanisms that underlie 
disease-causing mutations in the hH1 C-terminus.  For example, the model suggests the 
insertion within the Ca2+-binding loop (1795insD) associated with both LQT3 and the 
Brugada arrhythmia syndromes (Veldkamp et al. 2000) will alter the register of side 
chains coordinating the Ca2+ ion. E1784K, another LQT3 mutation (Wei et al. 1999), is 
located adjacent to the Ca2+-binding loop, and the model suggests this mutation could dis-
rupt the network of hydrogen bonds critical to the structural stability of the binding loop 
(Strynadka and James 1989).  Electrophysiologic, biophysical, and structural studies of 
hH1 constructs carrying these disease-linked mutations should provide insight into how 
modified Ca2+ binding in the EF-hand region influences hH1 dysfunction, and thereby 
shed light on the mechanisms of these inherited arrhythmia syndromes. 
Therefore, we undertook to first characterize the precise stretch of residues defin-
ing the folded core of the proximal hH1 C-terminus containing the EF-hand and calcium 
binding activity.  We also designed a series of mutations in the EF-hand to characterize 
unique aspects of the binding loop.  These results are described in Chapter III. 
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CHAPTER III 
 
REMOVAL OF THE IQ-MOTIF FROM HH1 RESULTS IN SIGNIFICANTLY RE-
DUCED CALCIUM AFFINITY IN THE HH1 C-TERMINUS 
 
 
 
Introduction  
As described in Chapter II, it has been established with a high level of confidence 
that calcium binds directly to the hH1 C-terminus, causing functional changes in channel 
behavior.  Mutations in the EF-hand calcium binding loop disrupt this binding and reduce 
or abolish calcium-dependent functional effects.  On the basis of these findings, further 
characterization of the EF-hand core in the hH1 C-terminus was undertaken.  Two ap-
proaches were taken.   
First, truncation mutants were generated in order to further define the folded re-
gion of the hH1 C-terminus.  Observations while working with hH1-CTD-148 suggested 
that this 148 residue construct is proteolytically sensitive at the C-terminus.  This obser-
vation is consistent with previous observations published in the literature (Zwerling et al. 
1991), and led to the hypothesis that further truncations could be made without adverse 
effect on folding of the EF-hand core. 
Second, mutational studies were undertaken in order to study the role of specific 
residues in the calcium binding loop.  Four single mutations that fall within the loop were 
designed for examination: D1790G, F1791A, M1793G, and E1799A.  Based on the prop-
erties of canonical EF-hand calcium binding loops, the two mutations involving acidic 
residues (D1790G and E1799A) were expected to lower calcium affinity.  F1791A is a 
control and was expected to have no effect on affinity.  M1793G was expected to either 
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increase calcium affinity or have no effect (Nelson and Chazin 1998).  As discussed in 
Chapter I, in canonical EF-hands the position 7 residue contributes its main chain oxygen 
to the chelation of calcium ion.  Since position 5 contributes an oxygen from its side 
chain, the position 6 residue must adopt an unusual backbone conformation favorable 
only for glycine, leading to strong conservation of glycine in this position.  Calcium bind-
ing in an EF-hand with a methionine at position 6, as there is in hH1, suggests that a 
higher energetic penalty is being paid during a calcium binding event for this site relative 
to a canonical EF-hand.  Mutation of position 6 from methionine to glycine would there-
fore possibly reduce or abolish this extra energetic penalty, a reduction which may trans-
late into an increased calcium affinity. 
The studies in this chapter confirm and extend our previous findings with regard 
to the presence and role of an intrinsic calcium sensing EF-hand motif in the proximal 
hH1 C-terminus.  Specifically, these experiments show that the stably folded component 
of hH1-CTD-148 can be found within the 93-residue region E1773-S1865, but that in-
termediate (sensor-range) calcium affinity requires the presence of downstream residues.  
 
Results 
 
The proximal 93-residues of the hH1 C-terminus are stably folded 
 
In order to determine the stretch of residues that defines the folded core of the 
calcium binding motif, two significantly truncated constructs (hH1-CTD-93, E1773-
S1865; hH1-CTD-120, E1773-I1892) relative to the one previously used (hH1-CTD-148, 
E1773-S1920) were generated.  The truncations were based on previously published sec-
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ondary structure predictions (Cormier et al. 2002b) and multiple sequence alignment, re-
moving the predicted 6th, or 5th and 6th, helices from the construct.  15N-1H HSQC NMR 
spectra were collected for these proteins in the presence of saturating calcium.  Figure 3.1 
shows 15N-1H HSQC spectra of hH1-CTD-93, hH1-CTD-120, and hH1-CTD-148.  Note 
especially the downfield regions of the spectra containing signals that are highly sensitive 
to the tertiary structure.  These overlays demonstrate that all of the downfield shifted 
peaks characteristic of the globular core are preserved even in the shortest construct.  The 
very small chemical shift differences imply that there is at most a minor conformational 
effect of leaving off the predicted fifth and sixth helices of the C-terminus.  Thus, the 
truncations do not adversely affect the folded core containing the globular EF-hand do-
main, which implies that the core is within hH1-CTD-93. 
 
Calcium binding to hH1-CTD-93 is observable by NMR 
15N-1H HSQC spectra of hH1-CTD-93 in the absence (2 mM BAPTA) and pres-
ence (20 mM CaCl2) of calcium revealed a significant number of calcium-dependent 
chemical shift perturbations (Figure 3.2a).  While the number of perturbations is large, it 
is clear from the magnitude of these changes that the conformational effect of calcium 
binding is significantly milder than that seen for a typical calcium sensor such as 
calmodulin.  Calcium-dependent changes in the 15N-1H spectra for these proteins are 
much more substantial, indicating more significant reorganization of the tertiary structure 
in these cases (e.g. Ikura et al. 1990; Skelton et al. 1992; Ishida et al. 2002).  (Ikura et al. 1990; Skelton et al. 1992; Ishida et al. 2002). 
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Figure 3.1:  NMR reveals that truncation to hH1-CTD-93 do not disrupt the folded EF-
hand core.  Shown here are zoomed regions of the 15N-1H HSQC NMR spectrum of 15N-
nat-hH1-CTD-148 (purple, both panels) with the spectra of (a) 15N-nat-hH1-CTD-93, red 
and (b) 15N-nat-hH1-CTD-120, blue.  All proteins were expressed without any tags and 
were exchanged into buffer containing 20 mM Tris, 5 mM BME, 20 mM CaCl2 at pH 
7.5.  See Appendix C for further details on the Materials and Methods.  Full spectra are 
included in Appendix D. 
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Figure 3.2:  Calcium-dependent changes in the NMR spectrum of hH1-CTD-93.  Shown 
are zoom regions of the 15N-1H HSQC NMR spectrum of 15N-His-hH1-CTD-93 in 
BAPTA (black, all panels) with spectra of the protein under the following conditions: (a) 
in CaCl2, red; (b) in EGTA, light blue; (c) TCA precipitated, light blue; (d) in MgCl2, 
green.  Full spectra are included in Appendix D. 
 
 
 
In order to verify that the chemical shift perturbations in hH1-CTD-93 are specifi-
cally related to the binding of calcium and not to changes induced by binding of BAPTA, 
protein was decalcified using two other protocols and also exchanged into calcium-free 
buffer containing 20 mM MgCl2 (Figure 3.2b-d; see Methods).  15N-1H HSQC spectra of 
the proteins decalcified in different ways overlay with the BAPTA spectrum (Figure 
3.2b,c), confirming that the observed chemical shift changes are not caused by BAPTA 
and are specifically related to the presence of the divalent ion.  The spectrum of the mag-
nesium loaded sample (Figure 3.2d) largely overlays with the BAPTA spectrum, indicat-
ing that the chemical shift perturbations are specifically related to the presence of cal-
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cium.  The small changes induced by magnesium are attributed to the fact that magne-
sium can bind in calcium binding sites with weak affinity, but without causing the con-
formational effects associated with calcium binding (Andersson et al. 1997).  The lack of 
conformational effect is suggested by the fact that a majority of peaks that shift signifi-
cantly in the presence of calcium do not shift at all in the presence of magnesium.  Those 
peaks that do shift upon binding magnesium are found, in part, to disappear (Figure 3.2d), 
presumably due to line broadening associated with chemical exchange. 
 
EF-hand mutations in hH1-CTD-93 did not disrupt structure 
 
 The four EF-hand calcium binding loop mutations (D1790G, F1791A, M1793G, 
and E1799A) discussed above were introduced into hH1-CTD-93.  Our strategy was to 
first assay the structural integrity of each mutant protein, then measure calcium affinity.  
CD and 15N-1H heteronuclear NMR were used for structural characterization.  To facili-
tate the analysis, the more stable and soluble His6-tagged constructs were used for these 
experiments.  Due to the potential for interference from the His6-tag, some of the calcium 
affinity measurements were performed using protein expressed without the tag and puri-
fied by other means (see Materials and Methods).  Figure 3.3 shows the CD and 15N-1H 
HSQC NMR data for the wild-type protein and each mutant.  The CD data indicates that 
the secondary structure content of each of these constructs is highly similar to that of the 
wild-type protein.  While there is a detectable difference in the CD spectrum of D1790G 
in the region between 220 and 230 nm as compared to the other constructs, the effect is 
not large enough to conclude that the structure of this mutant is significantly different.  
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Figure 3.3: Mutations in the hH1 EF-hand do not disrupt secondary or tertiary structure. 
(a) CD spectra of wild-type and all mutations show helical characters with characteristic 
minimum at 222 nm.  (b-f) Overlays of zooms of 15N-1H HSQC NMR spectra collected 
for wild-type or mutant protein, as indicated in the panel, under apo (blue) or Ca2+-loaded 
(red) conditions.  These indicate preservation of tertiary structure; some chemical shift 
perturbations versus wild-type are expected simply due to the introduction of mutations.  
Full spectra are included in Appendix D. 
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The NMR data confirms that the tertiary structure of each of the mutants is retained, as 
reflected in the overlap of signals in the spectrum of each mutant with signals in the wild-
type protein. 
 
Calcium binds to hH1-CTD-93 with mM affinity 
The calcium affinity of hH1-CTD-93 was determined by titration of calcium into 
calcium-free, BAPTA-free protein.  Attempts to monitor the titration by fluorescence and 
isothermal titration microcalorimetry were unsuccessful because, unknown at the time the 
measurement were undertaken, the calcium affinity of the 93-residue construct was much 
weaker than the calcium affinity of the 148-residue construct.   
 
 
Figure 3.4: Calcium titrations of hH1-CTD-93 monitored by NMR.  Changes in selected 
signals from the 15N-1H HSQC spectra of (a,b) wild-type 15N-His-hH1-CTD-93, (c) 
M1793G 15N-His-hH1-CTD-93, (d) E1799A 15N-His-hH1-CTD-93, and (e) wild-type 
15N-nat-hH1-CTD-93.  See text for affinity values.  Full spectra for panel a are included 
in Appendix D. 
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Based on the observed calcium-dependent chemical shift changes, NMR was used 
to monitor the calcium titration.  The titration of a representative peak in the 15N-1H 
HSQC spectrum of His-hH1-CTD-93 is shown in Figure 3.4a.  Calculation of the binding 
constant (average binding constant for 8 residues with significant chemical shift perturba-
tions) using this data revealed an extremely weak binding interaction (7.5 ± 0.6 mM; fit 
shown in Figure 3.4b).  This affinity is far weaker than the affinity measured previously 
for the longer hH1-CTD-148 construct (1.3 ± 1.2 µM), and is well outside the range of 
calcium affinity expected for a physiologically relevant calcium sensor.  
The accuracy of this dissociation constant was verified by repeating the calcium 
titration several times with wild-type protein.  Moreover, titrations of calcium into His-
M1793G and His-E1799A mutant protein (Figure 3.4c,d) provided similar results with Kd 
values of 4.7 ± 0.6 mM and 7.3 ± 0.9 mM, respectively.  Finally, to ensure that the re-
duced affinity was not caused by the His6-tag, a calcium titration was performed with 
hH1-CTD-93 construct expressed without the tag (Figure 3.4e).  Similar low affinity Kd 
values were measured, confirming that the EF-hand domain is insufficient on its own to 
attain high affinity calcium binding. 
 In light of the weak calcium binding affinity measured for hH1-CTD-93, the cal-
cium binding affinity measurement of hH1-CTD-148 reported in Chapter II was repeated.  
These new measurements took advantage of improved expression, purification, and de-
calcification protocols and provided binding constants with significantly higher precision 
than those reported in Chapter II.  Improved sample preparation also allowed recording of 
15N-1H HSQC spectra for both apo and calcium-loaded hH1-CTD-148.  These spectra 
confirm that the calcium-dependent chemical shift perturbations observed in hH1-CTD-
51 
93 are comparable to those seen in hH1-CTD-148 (Figure 3.5b).  Titration of calcium 
into hH1-CTD-148, monitored by NMR, provided an estimate of affinity (Kd < 10 µM) 
(Figure 3.5b).  A more accurate value of the dissociation constant was determined by 
monitoring calcium-dependent changes in intrinsic tryptophan fluorescence, yielding a 
value of 5.8 ± 0.3 µM (Figure 3.5a), fully consistent with our previous findings.  These 
results confirm the potential of the EF-hand domain of hH1 to serve as an effective cal-
cium sensor. 
 
 
Figure 3.5: Titration of calcium into 15N-hH1-CTD-148 monitored by 15N-1H HSQC 
NMR and by intrinsic tryptophan fluorescence reveal high affinity calcium binding.  (a) 
Titration of Ca2+ into nat-hH1-CTD-148 monitored by intrinsic tryptophan fluorescence. 
(b) [Ca2+] was 0 µM, 200 µM, 500 µM, 630 µM, 1800 µM for blue, green, yellow, or-
ange, and red respectively; protein concentration approximately 500 µM.  Note that the 
shift change is virtually saturated at 630 µM, indicating an affinity much stronger than the 
protein concentration (see Appendix B).  Full spectra are included in Appendix D. 
 
 
 
Discussion 
 
The observation of weak (mM range) calcium affinity in hH1-CTD-93 was not 
anticipated.  Our initial assumption was that the folded EF-hand core would retain full 
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calcium-binding capability; the fact that it does not, and that the additional 55 residues 
are necessary for high affinity calcium binding without playing a significant structural 
role, is highly provocative.  It suggests cross-talk between two calcium-dependent hH1 
regulatory pathways since both involve the IQ calmodulin-binding motif.  This type of 
direct communication between calcium sensors may function as some sort of detector for 
firing rate and/or intracellular calcium buildup, depending on the kinetics governing the 
various interactions. 
It is important to note that the NMR and fluorescence experiments reconfirmed 
our previous observation of high affinity calcium binding in hH1-CTD-148.  A recent 
report noted an inability to reproduce the calcium dependent changes in intrinsic trypto-
phan fluorescence even though the investigators were using a construct similar to ours 
(Kim, Ghosh, Liu et al. 2004).  However, although this team used a standard protocol for 
decalcification, no evidence was provided that the samples were fully decalcified.  Our 
previous observations showed that standard decalcification procedures are not always 
fully effective at decalcifying the hH1 EF-hand domain.  Hence, we believe that the high 
affinity calcium binding site remained occupied in their experiments, and consequently 
no calcium-dependent spectral changes were observed. 
When this group measured the intrinsic tryptophan fluorescence of their hH1-
CTD construct, they found an extremely blue-shifted tryptophan fluorescence emission 
maximum of approximately 325 nm, as compared to the maximum which we observed to 
occur at approximately 345 nm.  They suggest that this difference may indicate partial 
unfolding in our samples.  However, the dispersion of 15N-1H HSQC chemical shifts in 
our samples, reported both here and in Chapter II, unambiguously demonstrates the pres-
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ence of folded globular protein (Cavanagh 1996).  Our new results show calcium-
dependent NMR chemical shift perturbations and high affinity calcium binding in hH1-
CTD-148 by intrinsic tryptophan fluorescence and by NMR.  The affinity reported here is 
nearly identical to that obtained previously using a different construct, a different purifi-
cation protocol, and a different decalcification protocol.  These facts suggest that other 
factors, such as the aforementioned incomplete decalcification, may be involved in the 
inability of Kim et. al. to reproduce our results. 
The experiments reported here established the minimum region necessary for high 
affinity calcium binding in hH1.  More importantly, they suggest a potentially new and 
exciting role for the sixth helix in hH1-CTD-148, which contains an IQ motif.  This 
prompted a series of complementary spectroscopic and electrophysiologic studies related 
to the IQ motif region, which are described in Chapter IV. 
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CHAPTER IV 
 
THE HH1 C-TERMINAL IQ MOTIF PLAYS A DUAL ROLE  
IN CALCIUM-DEPENDENT REGULATION 
 
Introduction 
Chapter II provides detailed evidence that calcium is able to bind to an EF-hand 
found in the region E1788-E1799 of the hH1 C-terminal domain, and that arrhyth-
mogenic mutations in the EF-hand disrupt both the binding of calcium and the functional 
effects of calcium on the channel.  The experiments described in Chapter III revealed that 
while the region containing the proximal 93 residues of the C-terminal domain preserved 
the folded EF-hand core, this region is not sufficient for high affinity calcium binding.  
Truncation of the 55 residues C-terminal to the EF-hand domain results in a three order 
of magnitude drop in calcium affinity. 
The region R1897-S1925 at the C-terminus of hH1-CTD-148 contains an IQ-type 
calmodulin (CaM) binding motif (Tan et al. 2002b; Mori et al. 2003).  The evidence pro-
vided in Chapter III suggests that this may be the component needed for high affinity cal-
cium binding in the EF-hand.  The IQ motif is a common calmodulin binding motif (see 
Chapter I).  Briefly, the consensus sequence of the IQ motif is δQxxxβGxxxβxxδ, 
where δ represents any of Phe/Ile/Leu/Val and β represents either Lys or Arg (Bahler and 
Rhoads 2002).  The Gly at position 7 is only loosely conserved; while it is found is some 
human isoforms of the sodium channel, it is not present in hH1.  The final hydrophobic 
residue is likewise variably conserved, but it is found in all human sodium channel iso-
forms.  It is commonly held that the function of the IQ motif, which can bind apo-CaM, is 
to localize calmodulin at basal calcium levels so that the local concentration of CaM is 
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high near sites where it is to perform a calcium-dependent role (Alexander et al. 1987; 
Jurado et al. 1999).  It may also function to modulate the kinetics of calcium binding by 
increasing the off-rate of calcium, allowing more rapid responsiveness to calcium signals 
(Putkey et al. 2003). 
CaM has been reported to bind to the hH1 IQ-motif in a calcium-independent 
manner, i.e. it binds CaM in the absence of calcium (Mori et al. 2003), but the functional 
effect of CaM binding remains unclear.  The initial report described an enhancement of 
slow inactivation by the binding of Ca2+-CaM to the hH1 IQ motif (Tan et al. 2002b), but 
others have found different effects or no effect of CaM on hH1, though some have found 
that CaM may modulate other isoforms of the voltage-gated sodium channel family 
(Deschenes et al. 2002a; Herzog et al. 2003).  Further complicating the picture is a recent 
report suggesting that all calcium-dependent changes experienced by hH1 are mediated 
by CaM and that calcium does not bind directly to the EF-hand domain (Kim, Ghosh, Liu 
et al. 2004). 
Even absent conflicting reports, it remains difficult to understand the role of vari-
ous regulators (e.g. Ca2+, CaM, FHF1b, and Nedd; see Chapter I), given the critical lack 
of information about the mechanisms that underlie steady-state availability and slow in-
activation.  Characterization of arrhythmogenic mutations have uncovered regions of the 
channel that are important for various channel functions, and have in that way contributed 
to advances in understanding these mechanisms.  Since it is known that calcium is play-
ing a critical and possibly anti-arrhythmic role in channel function based on the data in 
Chapters II and III, further examination of this pathway may lead to important insights 
into the mechanisms of both normal and aberrant channel behavior. 
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This chapter describes the combination of electrophysiology, fluorescence and 
NMR approaches that were used to characterize one aspect of this pathway.  Interactions 
between the IQ motif and both calmodulin and the hH1 EF-hand domain are character-
ized.  Mutations in the IQ motif which disrupt calcium-dependent function of the channel 
are then introduced and characterized spectroscopically and electrophysiologically, re-
vealing that mutations in the IQ motif can indeed significantly disrupt calcium binding in 
the upstream EF-hand.  A mechanistic model for the regulation of hH1 by calcium is then 
explored in Chapter V. 
 
Results 
 
The IQ motif binds to hH1-CTD-93 in a Ca2+-dependent manner 
Given the significant difference in calcium affinity between hH1-CTD-148 and 
hH1-CTD-93, as described in Chapter III, we hypothesized that the sixth (“IQ”) helix is 
acting to tune the calcium affinity of the folded domain (hH1-CTD-93) during a calcium 
signaling event, even though, based on the truncation NMR data, this region is not play-
ing a significant structural role in the folding of the EF-hand domain. 
 
 
Figure 4.1: Canonical IQ motif sequence compared with the hH1 IQ motif.  Also indi-
cated are the locations of two IQ motif mutations introduced to ascertain their effect on 
calcium and calmodulin affinity. 
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 To explore this hypothesis, a 31-residue peptide corresponding to the region 
R1897-S1925 of hH1, centered on the putative IQ motif in the hH1-C-terminus, was gen-
erated.  This peptide was used in chemical shift perturbation assays to probe binding to 
15N-labeled hH1-CTD-93.  Figure 4.1 shows the primary sequence of the IQ motif pep-
tide. 
 Based on chemical shift perturbations, the IQ motif binds hH1-CTD-93 in both 
apo and calcium-loaded states; addition of the peptide causes selective broadening and/or 
shifting of a significant number of peaks (Figure 4.2).  Remarkably, many peaks that 
change upon the addition of peptide are also peaks that shift upon the addition of calcium, 
and the perturbations in some cases differentially affect the proton and/or nitrogen reso-
nance frequencies.  For example, a peak at 122 ppm in 15N and 8.4 ppm in 1H appears to 
shift primarily in the 1H dimension upon the addition of calcium, but primarily in 15N di-
mension upon the addition of peptide.  This observation suggests that IQ motif binding 
promotes the conformational change needed to bind calcium.  Thus, the peptide seems to 
play a role either in direct chelation of the calcium ion or in a conformational change in 
the EF-hand core that facilitates calcium binding.  It is also interesting to note that under 
calcium-loaded conditions, addition of the peptide causes the protein to precipitate sig-
nificantly.  This suggests that the presence of both peptide and calcium results in a con-
formational change that promotes aggregation of this protein construct. 
 The affinity of the IQ motif for hH1-CTD-93 was not determined, for both theo-
retical and practical reasons.  The measurement of the affinity as a bimolecular event 
would not accurately reflect the association of these two species because they are cova-
lently linked in vivo in the same polypeptide chain.  This results in a dramatic increase in 
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the local concentration of the IQ motif vis-à-vis the EF-hand.  Due to these considera-
tions, an in vitro bimolecular affinity measurement would dramatically underestimate the 
actual ratio of bound to free species in the channel.  From a practical standpoint, addition 
of the peptide causes precipitation of hH1-CTD-93.  During experiments, this results in 
an inability to hold the protein relatively constant while measuring the response of the 
system at various ligand concentrations, a critical requirement for accurate determination 
of Kd (see Appendix B).  Finally, the observation of intermediate and fast exchange phe-
nomena in the spectra allows us to coarsely estimate the bimolecular affinity as between 
50 µM and 500 µM.  While weak on its own, by factoring in the effect of covalent link-
age we conclude that interaction is likely to be physiologically relevant. 
 
 
 
Figure 4.2: IQ motif peptide binds to both apo- and Ca2+-hH1-CTD-93.  (a) The overlay 
of apo-hH1-CTD-93 in the absence (blue) and presence (red) of saturating peptide.  (b) 
Corresponding spectra for Ca2+-hH1-CTD-93.  The effects of the IQ motif are more pro-
nounced in presence of calcium as evidenced by greater selective exchange broadening in 
panel b.  Calcium-dependent chemical shift perturbations are not directionally the same 
as IQ-dependent perturbations.  Full spectra are included in Appendix D. 
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IQ motif mutations alter calcium affinity 
 In order to further characterize the role of the IQ motif in Ca2+-dependent regula-
tion of channel function, a collaboration with the laboratory of Dr. Jeffrey Balser was ini-
tiated to characterize the properties of IQ motif region mutations using electrophysiologi-
cal and spectroscopic techniques. 
 Two mutations were selected for characterization: a naturally occurring arrhyth-
mogenic mutation is found in the distal part of the IQ motif at position 1924, resulting in 
an alanine to threonine mutation (A1924T).  This mutation is known to cause Brugada 
syndrome and was observed to disrupt Ca2+-CaM interactions with the hH1 IQ motif by 
Tan and colleagues (Tan et al. 2001).  Another IQ mutation, I1908A/Q1909A (IQ/AA), 
was also examined because it had been previously used by others in the characterization 
of CaM interactions.  Figure 4.1 shows the location of these mutations in context of the 
wild-type IQ motif sequence. 
 
 
 
Figure 4.3: Mutations in the IQ motif diminish calcium-dependent changes in steady-
state availability.  (a) V1/2 for A1924T was: –90.87 ± 0.44 (n = 12) for Ca2+-free condi-
tions and –90.18 ± 0.71 (n = 13) for 1 µM Ca2+.  (b) V1/2 for IQ/AA was: –100.76 ± 1.05 
(n = 9) for virtually Ca2+-free conditions, and –100.03 ± 1.44 (n = 9), for 1 µM Ca2+.  
Data was collected by Tammy Wingo. 
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 Interestingly, these mutations have very different effects on the electrophysiologi-
cal properties of the channel.  A1924T was found to cause a rightward shift of the steady-
state availability curve at basal calcium levels, recapitulating the V1/2 observed for cal-
cium-loaded wild-type channel (Figure 4.3a).  In contrast, the IQ/AA mutation caused a 
shift in the availability curve to the left, in a manner similar to that observed for the 4X 
mutation discussed in Chapter II (Figure 4.3b).  In both cases, however, mutant channels 
failed to exhibit a the significant calcium-dependent shift in steady-state availability ob-
served in wild-type hH1 (Figure 2.2a). 
 
 
Figure 4.4: Mutations in the IQ motif of hH1-CTD-153 do not disrupt the structure of the 
EF-hand domain as compared to hH1-CTD-148.  Regions of the 15N-1H HSQC spectra of 
(a) wild-type hH1-CTD-153 (blue), (b) hH1-CTD-153-A1924T (blue), and (c) hH1-
CTD-153-IQAA (blue) overlayed with the spectrum of hH1-CTD-148 (red).  Full spectra 
are included in Appendix D. 
 
 
 
 In order to characterize the biophysical and structural effects of these mutations, a 
slightly longer construct of the hH1 C-terminus was required, extending from residues 
E1773-S1925 (hH1-CTD-153).  This construct was expressed without any tags and puri-
fied by standard methods.  The IQ-motif region mutations were introduced into hH1-
CTD-153 by site-directed mutagenesis. 
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 15N-1H HSQC NMR spectra of protein expressed from these constructs indicate 
that the hH1-CTD-153 wild-type and mutant constructs retain the same tertiary structure 
as hH1-CTD-148 (Figure 4.4).  Of note, point mutations normally cause at least one or 
two significant chemical shift perturbations in 15N-1H HSQC spectra, but none are ob-
served for the IQ motif mutants.  This observation suggests that the IQ region in this con-
struct is in chemical exchange and not visible in the NMR spectra, although it is possible 
that the resonances that are perturbed are buried in the crowded central region of the 
spectrum (7.5 to 8.5 ppm in 1H, 118 to 125 ppm in 15N). 
 
 
Figure 4.5: Titration of calcium into hH1-CTD-153 wild-type and mutants reveals sig-
nificantly reduced affinity in the IQ/AA mutant.  Binding affinity for hH1-CTD-153-WT 
was 15 ± 5 µM, and for hH1-CTD-153-A1924T was 18 ± 5 µM.  These values were not 
significantly different from one another.  The IQ/AA mutant showed affinity in the mM 
range, comparable to the affinity observed for the hH1-CTD-93 truncation mutant. 
 
 
 
 In order to confirm the biochemical function of the hH1-CTD-153 construct, cal-
cium affinity measurements were performed as described previously and a Kd value of 15 
± 5 µM was obtained (Figure 4.5a).  This affinity, is approximately tenfold weaker than 
the hH1-CTD-148 affinity reported in Chapter II and threefold weaker than the hH1-
CTD-148 affinity reported in Chapter III.  Although this value is outside the accepted 
range of affinities for calcium sensors, it is sufficiently close.  The origin of this effect 
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remains unknown.  However, as discussed in Chapter II, none of the in vitro affinity 
measurements are likely to reflect the actual calcium affinity in vivo.  Moreover, calcium 
need not saturate binding sites to have a functional effect on ion channels.  Because hun-
dreds or thousands of ion channels work in concert to produce ionic currents, partial satu-
ration of binding sites – and commensurate changes in the behavior of only a proportion 
of the channel population – may be enough to alter the macroscopic ion flow at the cellu-
lar level. 
 The effect of the mutations on calcium affinity was also measured.  hH1-CTD-
153-A1924T bound calcium with a Kd of 18 ± 5 µM, not significantly different from the 
affinity measured for wild-type (Figure 4.5b).  However, initial attempts to measure the 
calcium affinity of hH1-CTD-153-IQAA using tryptophan fluorescence failed – no con-
sistent change in fluorescence intensity as a function of calcium concentration could be 
measured.  On the suspicion that the affinity was much weaker than wild-type, a calcium 
titration was performed, monitoring changes by 15N-1H HSQC NMR spectroscopy in a 
manner analogous to that used in Chapter III for hH1-CTD-93 (Figure 3.4).  This titration 
confirmed our suspicions (Figure 4.5c); hH1-CTD-153-IQAA binds calcium with an af-
finity similar to that observed for hH1-CTD-93 and a thousand-fold weaker than wild-
type.  A coarse estimate of the Kd from these data yielded a value of 4.2 ± 2.3 mM. 
 
The IQ motif binds to calmodulin in a Ca2+-dependent manner  
 Previous studies have shown that calmodulin binds to the hH1 IQ motif.  Com-
bined with the data on the interaction of the IQ motif with hH1-CTD-93, this suggests 
that there may be competition with calmodulin for the IQ motif.  Thus, it may be impor-
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tant compare the relative strength of the IQ motif interaction with calmodulin versus 
hH1-CTD-93.  Although direct, quantitative measurement of the affinity of the IQ motif 
for hH1-CTD-93 is not possible for the reasons outlined above, the affinities for apo and 
calcium-loaded calmodulin provide insight into the overall mechanism of calcium-
dependent regulation of hH1. 
 To this end, titrations of IQ motif peptide into solutions of apo and calcium-
loaded CaM were performed, monitored by 15N-1H HSQC NMR spectroscopy (Figure 
4.6).  These titrations revealed that apo-CaM binds the peptide with slow exchange kinet-
ics on the NMR timescale, but Ca-CaM binds with intermediate to fast exchange kinetics.  
Since the binding constant Kd can be expressed as the ratio of the off-rate (koff) to the on-
rate (kon,) and assuming that the on-rate is diffusion limited, this change in kinetics im-
plies that Ca2+-CaM has a lower affinity for the peptide than apo-CaM. 
 
 
Figure 4.6: IQ motif peptide binds apo-CaM in slow exchange, and Ca2+-CaM in inter-
mediate to fast exchange.  (a) 1D slices of 2D 15N-1H HSQC NMR spectra collected 
while titrating peptide into apo-CaM.  These slices clearly demonstrate that the binding 
interaction is in slow exchange; peak a grows in volume as peptide is added while peak c 
diminishes in volume.  (b) Chemical shift perturbations induced in the 2D 15N-1H NMR 
spectrum of Ca2+-CaM as peptide is titrated in.  The chemical shift perturbation indicates 
fast or intermediate exchange; the broadening of this and other peaks at intermediate 
points in the titration confirm that the interaction is governed by intermediate exchange 
kinetics.  Full spectra are included in Appendix D. 
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 The binding affinity was quantified by monitoring the intrinsic tyrosine fluores-
cence of CaM during the titration of peptide into the protein.  This method has been used 
previously to monitor the binding of calcium to CaM (VanScyoc et al. 2002).  The titra-
tions revealed a weakening of affinity by more than tenfold in the calcium-loaded state 
(Figure 4.7a,b), with Kd values of 0.16 ± 0.04 µM for the apo-state versus 2.0 ± 0.3 µM 
for the Ca2+-loaded state.  
 The NMR spectra of the complex of the IQ motif with calmodulin could be used 
to localize the peptide binding site on calmodulin.  Chemical shift perturbations were in-
terpreted using previously published assignments of Ca2+-CaM from the BioMagRes-
Bank (http://www.bmrb.wisc.edu) and unpublished assignments of apo-CaM kindly pro-
vided by Dr. Ad Bax.  These results showed that apo-CaM (Appendix D) binds the IQ 
motif primarily via the C-lobe, whereas in the presence of calcium there is a shift in the 
mode of binding and interactions with both lobes of Ca2+-CaM are observed (Appendix 
D).  Although the assignments did not match perfectly with our spectra (caused by varia-
tions in the construct and/or conditions), these observations are consistent with the find-
ings of Mori et al., where the authors used circular dichroism to determine that the hH1 
IQ motif enhanced the helicity of only the C-lobe of apo-CaM, but enhanced the helicity 
of both lobes of Ca2+-CaM (Mori et al. 2003). 
 
IQ motif mutations affect calmodulin affinity  
 In order to confirm the important of the IQ motif, the IQ/AA and A1924T muta-
tions were introduced into the peptide construct using site-directed mutagenesis.  These 
peptides were prepared for binding studies to calmodulin monitored by changes in the  
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Figure 4.7: The hH1 IQ motif binds calmodulin, and IQ motif mutations can disrupt this 
interaction.  (a,b) Binding of the hH1 IQ motif peptide to apo and Ca2+-CaM.  (c,d) Bind-
ing of the hH1 IQ motif peptide mutant A1924T to apo and Ca2+-CaM.  (e,f) Binding of 
the hH1 IQ motif peptide mutant IQ/AA to apo and Ca2+-CaM.  The wild-type IQ motif 
peptide bound to apo-CaM with a Kd of 0.16 ± 0.04 µM and to Ca2+-CaM with a Kd of 
2.0 ± 0.3 µM.  The A1924T IQ peptide bound apo-CaM with a Kd of 1.3 ± 0.1 µM and 
Ca2+-CaM with a Kd of 15 ± 5 µM.  The IQ/AA peptide bound apo-CaM with a Kd of 
0.49 ± 0.05 µM, and Ca2+-CaM with a Kd of 3.4 ± 1.0 µM. 
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intrinsic tyrosine fluorescence of calmodulin.  Both mutations were found to reduce the 
affinity of the peptide for calmodulin, and in both the apo- and calcium loaded states 
(Figure 4.7c-f).  However, in contrast the effect of the mutations on calcium affinity, 
A1924T has a much larger effect on calmodulin affinity for the peptide than the IQ/AA 
mutation.  The A1924T IQ peptide bound apo-CaM with a Kd of 1.3 ± 0.1 µM and Ca2+-
CaM with a Kd of 15 ± 5 µM, in both cases about a ten-fold weaker affinity than wild-
type.   In contrast, the IQ/AA peptide bound apo-CaM with a Kd of 0.49 ± 0.05 µM, and 
Ca2+-CaM with a Kd of 3.4 ± 1.0 µM, approximately two-fold weaker than the wild-type 
IQ peptide. 
 
Discussion 
 It is clear from the data presented in this chapter that the hH1 IQ motif can bind 
both calmodulin and the hH1 EF-hand.  This data is consistent with our findings, de-
scribed in Chapter III, that residues downstream of the EF-hand are necessary for high 
affinity binding of calcium.  The observation that the IQ/AA mutation knocks down cal-
cium affinity 1000-fold supports the hypothesis that the IQ motif is playing a critical role 
in tuning the calcium affinity of the EF-hand. 
 It is complicated to compare the qualitative affinity of the IQ motif peptide for the 
EF-hand domain versus the quantitive affinity for calmodulin.  We believe that both the 
drop in affinity for calmodulin and the shift in the binding mode when calmodulin is cal-
cium loaded are significant.  In the apo-state, calmodulin is tightly bound to the IQ motif, 
and the interaction is mediated almost exclusively by the C-lobe.  However, upon cal-
cium loading, the overall affinity is more than ten-fold weaker and involves both lobes.  
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Because the interaction involves both lobes, the so-called “linkage effect” comes into 
play, i.e. two fairly weak interactions involving both the interaction with the N-lobe and 
the C-lobe mediate the synergistically stronger overall affinity.  Thus, it is very likely that 
the affinity of the C-lobe for the IQ motif has dropped significantly more than ten-fold.  
This also means that the off-rate of each of the lobes from the IQ motif from is signifi-
cantly higher than implied by the 2 µM Kd.   
 We also believe it is significant that the interaction between the IQ motif and 
Ca2+-CaM is in intermediate/fast exchange, just as the bimolecular interaction between 
the EF-hand and the IQ motif is in intermediate/fast exchange.  This implies that the af-
finities are in the same range, and the effective increase in the local concentration of the 
EF-hand as a result of covalent linkage likely means that the EF-hand is able to effec-
tively compete for the IQ motif when calmodulin becomes calcium loaded. 
 The studies described show that IQ motif mutations can significantly affect 
calmodulin affinity.  This is unsurprising, given what is known about IQ motifs and their 
ability to bind calmodulin.  What is surprising, however, is fact that the A1924T mutation 
causes a greater disruption than IQ/AA mutation.  A1924T is outside of the consensus 
sequence, but only just; it is three residues downstream of the final hydrophobic residue 
δ in the consensus sequence δQxxxβGxxxβxxδ.  IQ/AA on the other hand, disrupts 
residues thought to be central to the binding motif; indeed, the motif is named for this 
dipeptide.  While these findings bear out observations by some that residues upstream 
and downstream of the IQ motif are also important for calmodulin binding, that should 
also lead us to more closely examine different IQ motifs and how sequence might specify 
differences in calmodulin affinity or function. 
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 It is provocative that the leftward shift of the steady-state availability curve of the 
IQ/AA mutant, similar to the shift observed for EF-hand knockout mutations, is accom-
panied by a strong effect on calcium affinity but a weak effect on calmodulin affinity, 
while the rightward shift of the steady-state availability curve of the A1924T mutant is 
accompanied by a weak effect on calcium affinity but a strong effect on calmodulin affin-
ity.  While this observation is correlative, it suggests that the mechanisms by which these 
mutations disrupt the underlying calcium-dependent effects on steady-state availability 
are tied to differential effects on two different calcium-sensing elements: the hH1 EF-
hand hand and calmodulin. 
In summary, these data, combined with the data presented in Chapter II and III, 
provide evidence of a complex mechanism governing the calcium-dependent regulation 
of hH1.  In Chapter V, calcium-dependent regulation of other ion channels involved in 
excitability are presented with the goal of developing a model for the mechanism of regu-
lation of hH1. 
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CHAPTER V 
 
REVIEW OF CALCIUM-DEPENDENT REGULATION OF ION CHANNELS 
 
Introduction 
 As discussed in Chapter I, calcium plays an important role in hundreds of biologi-
cal processes as one of the most ubiquitous second messengers.  Intracellular calcium 
concentrations are tightly regulated to very low levels (~100 nM); the general mechanism 
by which calcium alters cellular biology involves a transient spike in calcium concentra-
tion, reaching over 10 µM and possibly much higher in certain local environments 
(Martonosi and Pikula 2003).  This represents a 100-fold change in calcium concentra-
tion.  As a rough approximation, this means that a calcium binding protein at 1 µM con-
centation with an affinity (Kd) of 1 µM will go from less than 10% saturated to over 85% 
saturated due to this change in calcium concentration.  (These numbers are highly de-
pendent on the concentration of the calcium-binding protein in question as well as the 
concentration of other proteins competing for calcium.   See Appendix B for a detailed 
discussion of binding constants.) 
 The EF-hand is the most common signal transduction element for translating this 
abrupt rise in calcium concentration into a biochemical signal.  Though EF-hands were 
described in detail in Chapter I and will not be reviewed again here, it is important to un-
derstand that calcium affinity is tuned not only by the calcium binding loop but also by 
many other elements of the EF-hand structural domain (Nelson et al. 2002; Bunick et al. 
2004).  This is observed, for example, in the difference between calmodulin and calbindin 
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D9k.  These two proteins have reasonable sequence homology, but the former has an af-
finity in the µM range, while the latter has calcium affinity in the nM range. 
 The mechanisms for regulating intracellular calcium concentrations in excitable 
cells involve, in part, feedback mechanisms where calcium acts directly or indirectly on 
ion channels.  Other mechanisms, such as those involving ion exchangers or GPCR’s, are 
important but outside the scope of the current discussion.  (Appendix A describes work 
done to characterize the calmodulin mediated calcium-dependent regulation of the G-
protein coupled vasopressin receptor V2R.)  The purpose of this chapter is to briefly sur-
vey these ion channel feedback mechanisms in order to gain some appreciation of the 
variations and commonalities in calcium-dependent regulation of these channels. 
 Calcium appears to regulate the function of nearly every channel involved in exci-
tation.  To briefly review the events of an action potential in myocytes: voltage-gated so-
dium channels open following an initial depolarization event, leading to rapid depolariza-
tion.  The data in support of this thesis strongly suggest that sodium channels are regu-
lated by calcium and calmodulin.  Dihydropyridine sensitive L-type calcium channels 
(LTCC) on the cell surface open concurrently, resulting in an inward rush of calcium 
ions.  T-tubules transmit the depolarization to the interior, where more LTCC’s also open, 
resulting in further calcium release into the cytoplasm (Sperelakis 2001).  The LTCC’s 
interact with ryanodine receptors (RyR), which are found on the sarcoplasmic reticulum 
(SR).  Activation of LTCC’s leads to activation of RyR’s, releasing calcium stored in the 
SR into the cytoplasm.  Both of these calcium-conducting membrane proteins are tightly 
regulated by calcium, resulting variably in positive or negative feedback regulation of 
calcium release, depending on calcium concentration.  Throughout this process, espe-
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cially towards the middle and late stages of the action potential, potassium channels open, 
resulting in repolarization of the cell membrane.  Certain members of the potassium 
channel family are regulated by calcium.  The contributions of various currents to the 
overall action potential are shown in Figure 5.1 (Tamargo et al. 2004). 
 
 
 
Figure 5.1: The contributions of various ionic currents to an action potential.  Panel a 
demonstrates the changes in transmembrane potential that occur during an action poten-
tial (also shown in Figure 1.1).  Panel b indicates the currents of sodium (INa), calcium 
(ICaL), and potassium (IK…) that occur during the course of the action potential.  Panel c 
diagrams in a very general way the channel openings, closings, and inactivations that oc-
cur during an action potential, where the red cylinder represents a single myocyte. Panels 
a and b adapted with permission from Tamargo et al 2004. 
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 This chapter reviews calcium dependent mechanisms of ion channel regulation in 
greater detail, culminating in a proposed model for the calcium-dependent regulation of 
hH1 based on the evidence provided in this thesis and other information that has been 
published. 
 
Voltage-gated sodium channel 
 Prior to the publication of the data presented in Chapter II (Wingo et al. 2004), the 
presence of an EF-hand in hH1 and other voltage-gated sodium channels was completely 
unknown.  The IQ motif had been reported in the literature, and because of the well-
known role of the IQ motif in mediating calmodulin interactions, a number of groups 
have published data on the role of calmodulin in the regulation of sodium channel func-
tion.   
 The first report related to the IQ motif was published by Dr. Jeffrey Balser and 
colleagues in 2002 (Tan et al. 2002a).  The main data presented were electrophysiological 
results showing the effect of exogenous Ca2+-calmodulin added to the pipette solution on 
hH1, enhancing its entry into a slow inactivated state.  The study also presented gel shift 
data indicating that the IQ motif produces a gel shift of CaM in the presence of calcium, 
but not in the absence of calcium.  We now know that this doesn’t reflect whether or not 
the peptide is able to bind calmodulin, since there are data in this thesis and in a pub-
lished paper (Mori et al. 2003) reporting lobe specific binding of calmodulin to the IQ 
motif, in both the presence and absence of calcium.  The latter reports CD measurements 
indicating that the IQ peptide enhances the helicity of only the C-lobe of calmodulin in 
the absence of calcium, but enhances the helicity of both lobes in the presence of cal-
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cium.  These data are fully consistent with the detailed NMR structural analysis reported 
in Chapter IV, which found the same calcium-dependent lobe specificity. 
 Contradictory to both of these studies was a previous report that calmodulin had 
no effect on hH1, although a CaM-dependent effect was found for hSkm1, the skeletal 
muscle isoform of the channel (Deschenes et al. 2002a).  These authors also detected that 
inhibition of CaM-dependent kinase II affected channel function.  Interestingly, close ex-
amination of the data uncovers an effect not noticed by the authors – namely that calcium 
has a direct effect on channel function.  A second group failed to detect an interaction 
between hH1 and calmodulin (Herzog et al. 2003). 
 As is clear from this discussion, the state of knowledge regarding calcium-
dependent regulation of voltage-gated sodium channels was still in its infancy prior to the 
studies reported in Chapter II.  In order to better understand the context of the findings 
reported in this thesis, the mechanisms that underlie calcium-dependent regulation of 
other channels have been examined in the anticipation that some commonalities may 
emerge. 
 
L-type calcium channel 
 The dihydropyridine sensitive L-type calcium channel (CaV1.2, LTCC) is an in-
teresting case study in the regulation of ion channels by calcium because it exhibits 
strong calcium-dependent behavior.  This protein has the layout of a prototypic voltage-
gated calcium channel, containing four domains of six transmembrane helices each.  The 
channel undergoes inactivation with a fairly slow (~1000 ms) rate constant in the pres-
74 
ence of barium, a divalent commonly used to mimic calcium, but inactivation speeds up 
five-fold (~200 ms) in the presence of calcium. 
 It has been long recognized that the channel contains an EF-hand in the proximal 
part of the C-terminus (Babitch 1990).  This region was initially proposed (de Leon et al. 
1995) to mediate calcium-dependent inactivation of this channel, but subsequent studies 
have ruled this out (Zhou et al. 1997; Peterson et al. 2000).  Sequence analysis suggests 
that this EF-hand may not even bind calcium with any significant affinity; there is a 
proline at position 2, and position 5 is a lysine instead of an acidic residue (Zhou et al. 
1997).  
 In light of these and other revelations, the calcium-dependent behavior of the 
channel is now attributed to a calmodulin-mediated mechanism.  It has been discovered 
that a number of noncontiguous sites in the C-terminus provide binding sites for 
calmodulin, including a canonical IQ-type motif (Pitt et al. 2001; Erickson et al. 2003; 
Xiong et al. 2005).  These motifs were discussed in the introduction to Chapter IV, and 
are known to bind apo (calcium-free) calmodulin.  It is commonly held that a major role 
for IQ motifs is to recruit calmodulin at basal calcium levels, which then serves as the 
calcium sensor for local calcium-dependent events; this appears to be the case for L-type 
calcium channels. 
 A number of proposals have been made for the mechanism of calcium-dependent 
behavior in this channel.  The most recent, proposed by Geoffrey Pitt and colleagues 
(Kim, Ghosh, Nunziato et al. 2004), integrates data related to calcium-dependent binding 
of calmodulin sites in the LTCC C-terminus with new mutational data and newly uncov-
ered interactions between the C-terminus and the I-II linker “inactivation particle”. 
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Figure 5.2: The proposed mechanism of calcium-dependent inactivation in CaV1.2.  Top 
left figure shows the channel in the open state.  Dotted lines from the EF-domain to the I-
II region and to the IQ/A/C region indicate binding interactions.  In the absence of cal-
cium, these interactions must be interrupted for I-II mediated inactivation.  In the pres-
ence of calcium, conformational changes allow the I-II to inactivate while preserving the 
I-II/EF interaction, speeding the process fivefold.  Figure based on Kim et al 2004. 
 
 
 
 The authors propose that the EF-hand region serves a structural role in calcium-
dependent channel behavior.  According to their proposal, the complex of calmodulin and 
the calmodulin-binding-region in the C-terminus interacts constitutively with the EF-
hand.  The EF-hand, in turn, interacts with the I-II linker in a way which inhibits I-II me-
diated channel inactivation.  Under basal calcium conditions, this results in slowing of I-
II mediated inactivation.  During conditions of elevated calcium, however, conforma-
tional changes in calmodulin release the EF-hand and allow the I-II linker to inactivate 
the channel more quickly.  The proposed model elegantly ties voltage-dependent inacti-
vation and calcium-dependent inactivation into a single mechanism, providing a mecha-
76 
nistic model for calcium-dependent effects on both of these supposedly independent 
types of inactivation.  The proposed mechanism of action is summarized in Figure 5.2. 
 
Ryanodine receptors 
 L-type calcium channels found in the transverse (T) tubule system of myocytes 
play a key role in stimulating calcium release from the sarcoplasmic reticulum (SR) of 
muscle cells (Marx et al. 2001).  The T-tubule system, formed by invaginations of the cell 
membrane, conducts depolarizations on the surface deep into the interior.  Depolarization 
activates LTCC’s.  As discussed, this results in calcium flow from the T-tubule system 
into the cytoplasm.  This process also activates ryanodine receptors (RyR).  These recep-
tors are found on the SR membrane at locations physically proximate to the T-tubule 
(Franzini-Armstrong et al. 1999; Bers 2004).  Ryanodine receptors are massive (~5000 
amino acid) proteins with four to twelve transmembrane helices that form tetrameric 
structures that are able to conduct calcium (stored in the SR lumen under resting condi-
tions) when activated by LTCC (Bers 2004).   Most of the bulk of the protein is on the 
cytoplasmic face of the SR membrane, forming 27 nm x 27 nm x 14 nm “feet,” which 
can be visualized by electron microscopy (Sharma et al. 1998; Samso and Wagenknecht 
2002; Wagenknecht and Samso 2002) in close association with L-type calcium channels 
(more so in skeletal than in cardiac muscle) as shown in Figure 5.3. 
 Three isoforms of RyR are found in mammals (Bers 2004).  RyR1 is found pre-
dominantly in skeletal muscle, and RyR2 in cardiac muscle.  RyR3 has more widespread 
distribution but is also found in muscle.  These channels are activated by ATP and low 
µM cytoplasmic calcium (calcium-induced calcium release), but inhibited by calmodulin 
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and mM range cytoplasmic calcium (Martonosi and Pikula 2003).  These receptors con-
tain two low-calcium-affinity EF-hands, only one of which is thought to bind calcium 
(Hamada et al. 2002).  Because the affinity is low, it is assumed that this EF-hand is in-
volved somehow in channel inactivation, but little is known about the mechanisms by 
which calcium-dependent activation and inactivation occur.   
 
 
Figure 5.3: Three-dimensional reconstruction of the structure of the ryanodine receptor 
(RyR) tetramer by high-resolution electron microscopy.  Panel a shows a side view and 
emphasizes the proximity of RyR to L-type calcium channels in the T-tubule system.  
Panel b shows a view from the cytoplasmic perspective, and panel c shows a view from 
the SR lumen perspective.  The location of calmodulin binding on a single subunit of the 
tetramer is indicated.  Figure modified with permission from Bers 2004. 
 
 
 
 Not much is known about the calmodulin dependent processes regulating the pro-
tein, either.  Calmodulin binding sites have been characterized by high resolution electron 
microscopy, which have elucidated a pocket on the massive cytoplasmic “foot” where 
calmodulin binds (Samso and Wagenknecht 2002).  Apo-calmodulin is able to bind to the 
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RyR, and the conformational changes accompanying the calcium-loading of calmodulin 
are thought to cause the calmodulin binding site to shift by a few amino acids; the change 
in position of calmodulin is observable by high resolution EM.  Calmodulin is known to 
have different effects on the different isoforms of the RyR, but in all cases inhibits cal-
cium release at higher calcium concentrations.  A significant amount of work remains to 
be done to understand these and other mechanisms that regulate these channels. 
 
Potassium channels 
 Potassium channels play an important role in the action potential cycle by repolar-
izing the cell membrane to complete the action potential, preparing the cell for the next 
action potential.  A large number of potassium channels also act during various phases of 
the action potential to modulate membrane potential shifts caused by the flux of sodium 
and calcium ions as well.  As discussed in Chapter I, some voltage-gated potassium 
channels open slowly compared to sodium channels, with the result that they begin to act 
just as sodium channels inactivate.  Another subset of potassium channels, the so-called 
inward rectifiers, activate and then inactivate extremely rapidly during initial depolariza-
tion, resulting in little to no conduction of potassium ion.  During the course of the action 
potential, however, these channels recover from inactivation and are able to activate 
again if the membrane potential is more positive than -30 mV.  During this second activa-
tion, the channels will remain open longer if the membrane potential is between 0 mV 
and -30 mV.  This results in increased potassium current and acceleration of repolariza-
tion. 
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 A third subset of potassium channels, the focus of the discussion here, are the so-
called calcium-activated potassium channels (KCa).  These channels open in response to 
calcium and act in the late phase of the action potential to contribute potassium currents 
towards repolarization of the cell in response to elevated intracellular calcium.  Three dif-
ferent subtypes of KCa have been identified on the basis of conductance: big conductance 
(BKCa ), intermediate conductance (IKCa), and small conductance (SKCa) (Stocker 2004). 
BKCa channels 
 BKCa channels are expressed in smooth muscle (Brayden and Nelson 1992) and 
nerve cells (Robitaille et al. 1993; Moczydlowski 2004).  Recently, they have also been 
implicated in functions as diverse as innate immunity in neutrophil leukocytes 
(Ahluwalia et al. 2004) and protection against ischemia in cardiac myocyes (Xu et al. 
2002).  The channels appear to have the canonical 6-transmembrane topology, with a 
number of positively charged residues in the S4 segment.  Interestingly, however, hydro-
pathy plots indicate that there may be as many as five more transmembrane helices, one 
amino-terminal to the S1 segment (termed S0) and four distal to S6 (termed S7-S10).  
The channels are able to respond to both voltage signals and calcium signals (Cox 2005). 
 At the present time, there remains quite a bit of controversy over the number, af-
finity, and location of calcium binding sites in BKCa.  What is clear is that there are no 
canonical calcium binding sites anywhere in the protein; the mechanisms of calcium 
binding are hotly disputed.  Domain swapping studies across species have uncovered that 
transfer of the distal transmembrane segments can transfer calcium dependent properties 
across species (Wei et al. 1994), and others have shown by alanine-scanning mutagenesis 
that an acid-rich region in the intracellular S9-S10 loop is important for calcium binding 
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(Bao et al. 2004).  This region has been termed the “calcium-bowl” and likely serves as 
one of the calcium binding sites in the protein. 
 Others have shown, however, that most of the voltage- and calcium-dependent 
properties of the channel are retained even when the last four transmembrane helices S7-
S10 are truncated (Piskorowski and Aldrich 2002).  This, combined with the lack of hard, 
direct evidence of calcium binding in the calcium-bowl, confirms that many questions 
about calcium binding in BKCa channels remain to be explored. 
SKCa and IKCa channels 
 SKCa channels are expressed throughout the body in muscle and nerve cells 
(Vergara et al. 1998; Bond et al. 2005).  In humans, this family is comprised of four 
members encoded by the genes SK1, SK2, SK3, and IK1 (Bond et al. 2005).  Note that the 
intermediate conductance channel is included in this family; although it has a larger sin-
gle-channel conductance and different drug sensitivity than the other members of the 
family, sequence homology indicates that this channel functions in a similar manner and 
is closely related to SKCa channels.  The initial separation of these channels into a sepa-
rate classification stemmed from the fact that SK isoforms were sensitive to the bee 
venom toxin apamin, whereas the IK isoforms were not.  SKCa channels are the only 
known target of apamin (Bond et al. 2005). 
 Each of these channels has the canonical transmembrane topology of potassium 
channels, namely, each channel has six transmembrane helices and tetramerizes to form a 
functional channel.  The S4 segments in voltage-gated potassium channels (KV) carry 
positively charged residues important for voltage-dependent gating.  In SKCa channels 
five of these residues are mutated, likely explaining the voltage-independent behavior of 
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these channels (Stocker 2004).  The focus of research on the three SK isoforms of this 
channel has been mainly restricted to their function in neural contexts, but it has been 
demonstrated that the SK2 isoform is expressed in the atria and ventricles of both human 
and mouse heart (Xu et al. 2003).  Apamin blockade results in substantially longer lasting 
plateau and repolarization phases of the cardiac action potential.  This and other observa-
tions in this report revealed both the presence of SK2 in cardiac myocytes and that the 
role of SK2 in this context is to accelerate repolarization of the cell following activation 
and calcium-mediated excitation-contraction coupling. 
 Unlike BKCa channels, quite a bit is known about the structural mechanism of cal-
cium-dependent sensitivity and gating in SKCa channels.  The proximal C-terminal do-
main of the channel binds calmodulin via novel motifs that do not conform to known 
Ca2+-independent CaM binding motifs (such as the IQ motif) or Ca2+-dependent motifs 
(such as the 1:5:8:14 motif).  These regions instead bind calmodulin in such a way that 
the C-terminal lobe of calmodulin appears to mediate a Ca2+-independent interaction with 
the channel, while the N-terminal lobe mediates Ca2+-dependent changes to these interac-
tions (Keen et al. 1999).  This information is based on biochemical data and crystal struc-
tures of the SKCa Ca2+-binding domain in complex with both apo (Schumacher et al. 
2004) and Ca2+-loaded calmodulin (Schumacher et al. 2001).  Of note is the fact that in 
the “Ca2+-loaded structure” only the N-lobe EF-hand calcium-binding sites are occupied 
by calcium. 
 Based on these structures, it appears that the binding of calcium to the N-lobe of 
calmodulin orders large parts of the SKCa C-terminus.  At the same time, the conforma-
tion of the binding surface between the calmodulin C-lobe and the SKCa C-terminus alters 
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significantly, reorienting the helical residues in the interaction region (residues 430-440) 
by greater than 90º (Schumacher et al. 2004).  Schumacher et al. propose, based on com-
parison of their structure with the Ca2+-CaM/SKCa structure, that this rotation may di-
rectly result in gating of the channel.  Since these changes occur in the proximal C-
terminus, they directly affect the covalently attached inner helix gate of the channel.  In 
their view, a rotation of this magnitude will likely cause significant conformational 
change in the gate, resulting in channel opening.  This proposed mechanism is summa-
rized in Figure 5.4. 
 
 
 
Figure 5.4: Proposed mechanism for calcium dependent activation of SKCa channels.  
Closed channels, at left, constitutively bind the C-lobe of calmodulin.  Calcium binding 
causes a > 90º rotation in the 430-440 segment of the SKCa C-terminus (light blue cylin-
der), altering the conformation of S6 and gating the channel to the open position.  Cal-
cium binding also causes a significant ordering of other parts of the C-terminus as well; 
the crystal structure of Ca2+-CaM with the SKCa-CTD is a domain swapped dimer with 
both lobes of CaM binding different parts of the SKCa-CTD. 
 
 
 
Discussion 
This dissertation has been devoted to examining and extending electrophysiologi-
cal evidence that calcium regulates the cardiac voltage-gated sodium channel hH1.  The 
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most likely explanation for our data is that calcium regulates hH1 channel function via a 
mechanism that links the intrinsic EF-hand calcium sensor to the extrinsic calcium sensor 
calmodulin.  The focal point for this crosstalk is the hH1 C-terminal IQ motif, which both 
recruits apo-CaM and acts to raise the calcium affinity of the intrinsic calcium binding 
motif by approximately three orders of magnitude. 
 
 
Figure 5.5: Model for the action of calcium in the hH1 C-terminus.  (a) At basal levels of 
calcium in the cell, calmodulin is localized to the IQ motif, bound via the C-lobe.  (b) As 
calcium levels rise, calmodulin binds calcium, which (c) weakens and alters the CaM/IQ 
interaction.  The consequent release (d) of one or both CaM domains enables the IQ motif 
(light blue cylinder) to interact with the EF-hand core, raising its calcium affinity by three 
orders of magnitude (red calcium binding loop).  (e) Calcium binds in that site. 
 
 
 
Combining all available evidence, the following model for the mechanism of cal-
cium-dependent regulation of hH1 is proposed (Figure 5.5).  As indicated by NMR and 
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fluorescence titration data in Chapter IV, calmodulin is bound to the hH1 IQ motif via its 
C-lobe at basal calcium levels with nM affinity.  Upon an increase in calcium levels, the 
binding of calcium to CaM causes the conformation of CaM to change, weakening and 
altering the CaM/IQ interaction, also demonstrated by NMR and fluorescence titration 
data in Chapter IV.  One or both lobes of calcium-loaded calmodulin are then more read-
ily able to dissociate.  The partial or complete dissociation of CaM frees the IQ motif to 
bind to the EF-hand domain, as NMR data in Chapter IV shows will happen in the ab-
sence of calmodulin.  This causes a concomitant calcium-dependent change in the con-
formation of the EF-hand domain, helping drive the equilibrium toward IQ interaction 
with the EF-hand domain and freeing up CaM.  As shown by data in Chapters III and IV, 
the EF-hand domain interacting with the IQ has µM calcium affinity and will be able to 
bind calcium. 
 The sequestration of the IQ motif by CaM, and the subsequent partial or complete 
dissociation of CaM upon calcium loading, is central to the model presented.  There is 
significant evidence supporting the idea that Ca2+-CaM dissociates from the hH1 IQ mo-
tif during a calcium signaling event.  For example, the studies described in Chapter II 
(Figure 2.2b) demonstrated that the addition of Ca2+-CaM inhibitory peptide CaMKII-
290-309 did not affect calcium-dependent changes in steady state availability.  Since 
blocking Ca2+-CaM with the peptide had no effect on steady-state availability, the impli-
cation is that the EF-hand mediates at least this aspect of calcium responsiveness.  If this 
is the case, it is likely either that the binding mode of Ca2+-CaM to the IQ is permissive 
of IQ/EF-hand interactions, or that one or both lobes of Ca2+-CaM is recruited elsewhere.  
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The latter idea will be explored further in Chapter VI, where preliminary data indicating 
that Ca2+-CaM interacts with another part of the channel is discussed. 
This model bears some resemblance to the one proposed by Kim et al. for the L-
type calcium channel (CaV1.2).  Both pair an IQ motif with an intrinsic EF-hand in the C-
terminus.  However, the overall mechanism of calcium-dependent regulation is quite dif-
ferent.  The major difference is that the proposed mechanism for CaV1.2 relies on the EF-
hand domain to transduce a calcium-binding signal that occurs at CaM, whereas our pro-
posal for NaV1.5 suggests that the IQ-motif is the site of interaction between the CTD and 
the cytoplasmic loop.  Additionally, it appears that the interaction of CaM with the Ca2+-
channel is mediated by a number of noncontiguous stretches of residues in the C-
terminus, whereas the IQ motif is necessary and sufficient for the interaction of CaM 
with the Na+-channel.  Another key difference is that the intrinsic calcium binding site 
does not play a role in calcium-dependent properties of CaV1.2, but, as described in 
Chapter II, mediates calcium-dependent changes in the voltage-dependent steady state 
availability of hH1.  Finally, the evidence in hH1 favors a model where CaM dissociates 
or binds elsewhere on the channel, whereas the proposed mechanism in CaV1.2 requires 
CaM to remain associated with the C-terminus. 
 As is clear from the examples described in this chapter, evolution has taken great 
pains to make calcium signals self-limiting.  The existence of calcium-dependent feed-
back mechanisms in sodium, potassium, and calcium signaling underlines the importance 
of regulating intracellular calcium levels.  The calcium-dependent alterations in the ki-
netic behavior of these channels likely tune the peak and trough calcium concentrations 
during an action potential.  This effect is both direct, by modulation of calcium current, 
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and indirect, by providing a calcium-dependent repolarization mechanism.  These proc-
esses may also provide some protection against pathological processes such as ischemia 
in which both extracellular and intracellular calcium concentrations rise significantly.   
Calmodulin plays a significant role in many of these regulatory processes, but in-
trinsic calcium binding sites also regulate many of these channels as well.  Further study 
of these systems will likely lead to new understanding of how these regulatory systems 
evolved and the specific biochemical reasons for why these sites were conserved.  Bigger 
discoveries may also come from better understanding of these channels.  For example, it 
is likely that BKCa channels are regulated by a novel calcium binding protein or contain a 
novel intrinsic calcium binding motif.  Characterization of this motif may uncover similar 
motifs in other proteins not currently recognized as calcium binding proteins.  A better 
molecular understanding of the mechanisms behind calcium-dependent control of these 
channels may also lead to new strategies for anti-arrhythmic and anti-epileptic therapy. 
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CHAPTER VI 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Summary  
 The protein channel mediating the rapid depolarization of cardiac tissue during 
contraction, the voltage-gated sodium channel known most commonly as hH1 or NaV1.5, 
is regulated by intracellular calcium concentrations.  The studies and analyses presented 
in this dissertation have shown that this calcium sensitivity is mediated by both intrinsic 
and extrinsic calcium sensing pathways.  These results strongly imply at least some level 
of crosstalk between these pathways.  Three naturally occurring arrhythmogenic muta-
tions, D1790G, ins1795D, and A1924T, occur in regions of the channel responsible for 
mediating these calcium dependent effects and have been shown to alter calcium-
dependent behavior.  In this chapter I examine this data in the context of the literature and 
other information currently available to propose future directions. 
 
Future Directions 
 
 
What is the structure of the hH1 C-terminal EF-hand?  To what extent are there 
conformational changes associated with Ca2+-binding? 
 
 In order to lay to rest many of the open questions surrounding the roles being 
played by calcium and by calmodulin, the three-dimensional structure of the proximal 
portion of the C-terminal domain at atomic resolution should be determined.  This infor-
mation will reveal at least four important pieces of information:  a) the location of bound 
calcium ions and the identity of the residues that chelate the ion, b) the structure of the 
88 
folded globular domain, c) the location and orientation of residues whose conformation 
and/or electromagnetic environment are altered by the binding of calcium ion, and d) the 
interactions of the IQ motif with the EF-hand core that result in tuning of calcium affin-
ity. 
 While some of these studies may be conducted using NMR, it is likely that an X-
ray crystal structure would provide higher resolution.  Comparison of 15N-1H HSQC data 
collected of hH1-CTD-93, hH1-CTD-125, hH1-CTD-148, and hH1-CTD-153 reveals 
that the additional residues past 125 do not result in many new resonance peaks in these 
correlation spectra.  This likely indicates some type of chemical exchange at an interme-
diate timescale, and further optimization of constructs and of conditions are needed to 
improve these spectra further, but also may not help.  In addition, it is possible that resi-
dues in the calcium binding loop are likewise in intermediate exchange, based on the fact 
that while some resonances shift in a calcium-dependent manner, they do not shift as 
dramatically as observed for other previously characterized calcium binding proteins.  
Attempts to date to assign the backbone of hH1-CTD-125 and of hH1-CTD-93 in our 
laboratory have proven to be difficult.  These observations suggest that both X-ray crys-
tallography and NMR will be challenging, but are nonetheless worth persistent effort be-
cause the end result will be extremely valuable for refining the mechanistic model to 
atomic resolution.   
 A comprehensive strategy for improving the stability and “foldedness” of the 
hH1-CTD constructs should be pursued.  It is essential to generate additional constructs, 
based on hH1-CTD-153, adding or subtracting residues from the N- and C-termini.  
NMR will be valuable for assaying new constructs.  Crystallization trials should be per-
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formed for both calcium-free/apo and calcium-loaded conditions, at a few different cal-
cium concentrations.  It will also be interesting to attempt co-crystallization of these con-
structs with calmodulin, at first only under apo conditions.  Because of the number of pa-
rameters that need to be varied, a robotic assembly capable of quickly screening a large 
number of conditions for a number of different samples will facilitate this process signifi-
cantly.  The use of a robotic assembly will also reduce the amount of protein required per 
condition screened.  If flexibility of the protein is intrinsic and prevents the growth of 
crystals which diffract to high resolution, then NMR remains the method of choice for 
atom-level characterization of protein structure. 
 
 
What is the structural mechanism of hH1 EF-hand domain function? 
 
Even in that absence of information about the molecular-level changes associated 
with calcium binding in the hH1 C-terminus, it may be possible to elucidate certain mo-
lecular details about calcium-dependent channel behavior.  While interactions between 
the hH1 EF-hand core and other regions of hH1 have not yet been identified, we do know 
that the conformational effect of calcium binding likely changes the binding surface pre-
sented by the EF-hand domain.  Preliminary chemical shift assignments indicate that 
some of the peaks observed to shift upon calcium binding represent residues outside the 
calcium binding loop, suggesting at least a modest change in conformation.  Two of the 
peaks that undergo fairly large shifts (~0.3 ppm in 1H) have tentatively been assigned to 
hydrophobic residues, raising the possibility that calcium-dependent rearrangements in-
volve a hydrophobic patch on the surface of the domain.  Far less likely is the possibility 
that there are substantial rearrangements in the tertiary structure of the molecule; this 
90 
would result in much larger and more widespread calcium-dependent changes in the 15N-
1H HSQC spectra. 
With the goal of identifying binding partners for the hH1 EF-hand domain, it may 
be useful to generate a series of expression constructs covering the cytoplasmic regions 
of the channel to “fish” for parts of the channel that interact with the C-terminus.  An-
other prospect for interaction with the C-terminus is the fibroblast growth factor homolo-
gous factor 1B (FHF1B).  Described in Chapter I, this protein is a newly identified bind-
ing partner of the hH1 C-terminus that is known to modulate channel function.  Interest-
ingly, the D1790G mutation knocks out this interaction, raising the possibility that the 
EF-hand domain is directly involved and/or that the interaction between hH1 and FHF1B 
is calcium-dependent.  We have already generated reagents for the examination of this 
interaction, but our preliminary binding and protease protection studies have been nega-
tive.   
It is also possible that the role of the EF-hand is to capture the IQ motif, freeing 
calmodulin to act elsewhere in the channel.  In this case, no target for the EF-hand is nec-
essary – or, rather, the IQ motif is the target.   
 
 
What is the role, if any, of Ca2+-calmodulin in regulating channel function? 
 
 This last concept, the idea that the role of the EF-hand is to sequester the IQ mo-
tif, raises questions about the role of Ca2+-loaded calmodulin in channel function.  There 
exists no clear consensus on the role of calmodulin in modulation of channel function.  
As discussed in Chapter IV, a number of studies have been performed to examine the 
electrophysiological effects of calmodulin binding.  Some have found an effect while 
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others have not.  As the studies described in this dissertation make clear, there is no doubt 
that calmodulin binds to the hH1 IQ motif.  The nanomolar affinity of apo-calmodulin for 
the motif virtually guarantees that CaM with be localized to this site.  How this binding 
translates to biological function remains unclear.  As discussed in Chapter V, we hy-
pothesize that Ca2+-loaded calmodulin, following a spike in intracellular calcium concen-
tration, partially or completely dissociates from the IQ motif.  The IQ motif then interacts 
with the EF-hand core.  The idea that Ca2+-CaM has another target on the channel is at-
tractive, because it would be an effective means to drive the release of the IQ motif.  For 
example, if the same molecule of CaM that is bound to the IQ motif in the apo state binds 
to a second site in the Ca2+-loaded conformation, the presence of this second site would 
also ease or eliminate the energetic cost of Ca2+-CaM dissociation from the IQ motif.  
This line of reasoning prompted a search for a Ca2+-CaM “sink” in hH1 – an intramolecu-
lar binding site with high affinity for Ca2+-CaM. 
Calmodulin has a number of putative secondary binding sites in hH1 in addition 
to the known IQ motif site.  These sites, as determined by submitting the hH1 sequence to 
the calmodulin binding site predictor (created by the laboratory of Dr. Mitsuhiko Ikura), 
are shown in Figure 6.1. 
 We have begun the process of analyzing whether these regions are actually capa-
ble of binding calmodulin.  Production of each of these regions, in a manner analogous to 
the production of the IQ motif peptide, will be followed by calmodulin binding experi-
ments to look for interactions and the strength of the interaction.  These results may yield 
further clues as to the molecular mechanism by which calmodulin acts, and follow up 
electrophysiological studies, introducing mutations to disrupt interactions which are un-
92 
covered, may clarify whether the interactions are physiologically relevant.  We have al-
ready found, for example, that calmodulin interacts with the III-IV linker region in a cal-
cium dependent manner (Figure 6.2). 
 
 
Figure 6.1:  Predicted sites of calmodulin binding in hH1 based on the primary sequence.  
The sites are indicated by yellow dumbbells.  Sites with a red circle and slash are sites 
which were ruled out as unrealistic calmodulin binding sites due to their predicted loca-
tion relative to the cell membrane. 
 
 
  
  The III-IV linker is the cytoplasmic loop between the third and fourth trans-
membrane domains of the channel, and serves as the “fast inactivation particle” for hH1.  
The introduction of certain mutations in the III-IV linker (at the “IFM motif”) prevents 
channels from inactivating after being gated open by a voltage pulse (McPhee et al. 1994; 
McPhee et al. 1995).  The solution structure of the hH1 III-IV linker peptide has been de-
termined (Rohl et al. 1999).  Analysis by 15N-1H HSQC NMR shows that the III-IV 
linker peptide interacts with CaM in a calcium-dependent manner, binding strongly to 
Ca2+-CaM but unable to bind apo-CaM with measurable affinity (Figure 6.2).  The identi-
fication of a putative Ca2+-CaM binding site in the III-IV linker is intriguing.  It is consis-
tent with recent reports that III-IV linker is involved in interactions with the hH1 C-
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terminus and CaM (Kim, Ghosh, Liu et al. 2004; Motoike et al. 2004).  However, those 
studies gave no direct evidence that the same molecule of calmodulin is involved with 
both IQ and III-IV interactions.  Likewise, it has yet to be demonstrated that the CaM/III-
IV interaction is physiologically relevant.  These findings suggest a number of future ex-
periments which need to be done in order to explore the role of CaM in this context; 
calmodulin may be critically important for normal channel function if it is serving to 
tether the hH1 C-terminus and the III-IV linker in some way. 
 
 
 
Figure 6.2: The III-IV linker interacts with calmodulin in a calcium-dependent manner.  
Both panels show 15N-labeled III-IV linker in the absence (black) and presence (red) of 
unlabeled calmodulin.  Panel a is under apo conditions, panel b is under calcium loaded 
conditions.   
 
 
 
Does calcium regulate other sodium channels? 
 
 The studies presented here raise the interesting question of whether the type of 
regulation we have reported occurs in other human voltage-gated sodium channel iso-
forms.  While a number of studies have been undertaken to examine the role of 
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calmodulin across various isoforms, no other group has attempted to characterize the di-
rect effect of calcium on any other voltage-gated sodium channel. 
 
 
 
Figure 6.3: Sequence homology in the EF-hand region and the IQ-motif regions of the 
nine canonical members of the human voltage-gated sodium channel family.  Sequences 
were aligned using Bioedit and BLAST.  NaX, a putative tenth member of the family, was 
not included in this analysis because it remains unclear whether this channel is expressed 
in humans, and if it is what role it is playing 
 
 
 
 An examination of the sequence homology between the members of the human 
sodium channel family (Figure 6.3) was interesting in this context.  The sequence align-
ment in the vicinity of both the EF-hand and the IQ motif reveals that both regions are 
strongly conserved in humans.  In the region of the EF-hand, positions 1, 3, 5 and 12 of 
the calcium binding loop all exhibit absolute conservation of acidic side-chains, and only 
positions 6 and 10 exhibit any nonconservative mutations.  Variations in the IQ motif se-
quence, though modest, may be correlated with differences in calmodulin affinity essen-
tial for isoform specific functionality.  The strong conservation of these regions suggests 
that the EF-hand and the IQ motif play an important role in basic channel function, and 
are likely to have deep evolutionary roots.  It may be worth looking for these motifs in 
channels from simpler organisms in order to ascertain the evolutionary conservation of 
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these features, which would further support the concept of functional relevance.  Such an 
examination may also uncover a simple model system that could facilitate future studies 
of the EF-hand and IQ motif. 
 
How do these regulatory elements function in the context of normal cardiac 
rhythm? 
 
 An important and provocative question, applicable to both cardiac and neurologi-
cal problems, is how alterations to normal channel function and regulatory processes at 
the molecular level (which lead to changes at the single channel and single cell level) af-
fect the function of integrated systems at the organ level.  The ability to model these 
processes accurately will likely aid in understanding how the perturbations caused by mu-
tations or by drugs translate into pharmacological or pathological effects.  
 The nascent field of complex systems research may provide tools for conducting 
these modeling experiments.  By building agent-based models of cellular and organ-level 
behavior, plugging in known kinetic and affinity information, it may be possible to un-
derstand or predict the subtle arrhythmogenic effects of alterations to channel behavior.  
These models may allow us to predict the types of alterations which are most and least 
likely to result in pathological effects, which could then in turn be used to develop im-
proved antiarrhythmic strategies.  
 
 
Is this regulatory element a viable antiarrhythmic drug target? 
 
Further analysis is required to understand the relative importance of the Ca2+ ef-
fects mediated through the hH1 EF-hand and the relation to mutations causing Na+ chan-
nel dysfunction.  Ca2+ modulation of Na+ channels through additional signalling path-
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ways that involve other second messengers and cofactors, including multivalent cations 
and ATP, must be examined.  Of particular relevance is that intracellular free Ca2+ rises in 
acquired conditions when the heart is particularly susceptible to fatal arrhythmias, such as 
during myocardial ischemia.  Since the maintenance of Na+ channel function appears to 
be a crucial determinant of survival under these conditions (Echt et al. 1991), the poten-
tial of the EF-hand as an antiarrhythmic target deserves extensive evaluation. 
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APPENDIX A 
 
CALMODULIN REGULATES THE G-PROTEIN COUPLED VASOPRESSIN RE-
CEPTOR V2 IN A CALCIUM-DEPENDENT MANNER 
 
Introduction  
 At approximately the time we were beginning to think about investigating the role 
of the hH1 C-terminal IQ motif, described in Chapter IV, I began a collaboration with a 
colleague in the Vanderbilt Medical Scientist Training Program, Hilary Nickols.  The col-
laboration grew out of discussion about her tentative findings that calmodulin could bind 
to the cytoplasmic C-terminal domain of the human vasopressin receptor V2R, a G-
protein coupled receptor (GPCR).  These findings were published (Nickols et al. 2004) 
 The V2R binds the agonist arginine vasopressin (AVP) and signals through the 
heterotrimeric protein Gs to promote water reabsorption and concentration of the urine in 
the collecting duct of the kidney (Cabral et al. 2000).  AVP, 8-arginine vasopressin, is a 
cyclic nonapeptide hormone that is secreted by the posterior pituitary in response to low 
urine osmolality or to decreased blood pressure.  AVP binds to the V2R on the baso-
lateral surface of the principal cells of the renal collecting duct, couples to Gs, and stimu-
lates adenylyl cyclase.  The subsequent increase in intracellular cAMP leads to activation 
of cAMP-dependent protein kinase, phosphorylation of aquaporin-2, and the translocation 
of pre-formed aquaporin-2-containing vesicles to the apical membrane of the principal 
cells (van Balkom et al. 2002).  This translocation appears to involve calcium in some 
(Chou et al. 2000; Yip 2002) but not other (Lorenz et al. 2003) experimental conditions.  
Because the calmodulin inhibitor W7 blocks the AVP-induced stimulation of water flow 
in the toad urinary bladder (Levine et al. 1981) and the rat inner medullary collecting duct 
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(Chou et al. 2000), calmodulin may play a role in AVP-induced insertion of aquaporin 2 
channels in these systems.  The ultimate insertion of aquaporin 2 water channels into the 
apical membrane allows the renal epithelial cells to absorb water, which accounts for the 
antidiuretic effect of AVP. 
 The C-terminal region of the V2R had been shown to be important for agonist-
mediated phosphorylation (Innamorati et al. 1997), receptor escape from the endoplasmic 
reticulum and transport to the plasma membrane (Schulein et al. 1998), sequestration and 
endocytosis of the receptor (Innamorati et al. 1997), and prevention of recycling 
(Innamorati et al. 1998) of the endocytosed V2R.  In the course of exploring proteins that 
might interact with the V2R C-terminus in a yeast two-hybrid screen, it was discovered 
that calmodulin was a potential binding partner.  These findings were further confirmed 
by immunoprecipitation assays (data not shown).   
 
Results 
 
The V2R C-terminus binds Ca2+-calmodulin but not apo-calmodulin 
 
To confirm and further characterize the observed interaction between the V2R C-
terminal RGR motif and calmodulin, we performed a series of NMR experiments using 
uniformly 15N-enriched calmodulin and a peptide fragment of the V2R C terminus con-
taining the RGR motif (RGRm).  For these experiments, RGRm was titrated into solu-
tions of calmodulin, in both the absence (190 µM calmodulin) and presence (150 µM 
calmodulin) of calcium.  As discussed elsewhere in this dissertation, the peaks in these 
two-dimensional spectra arise from backbone and side chain amide N-H groups, provid-
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ing a minimum of one probe for each residue in the protein.  The position of each peak is 
highly sensitive to both the structure and influences from the surrounding environment.  
 
 
 
Figure A.1: A peptide fragment of the V2R C-terminus binds to calmodulin in a Ca2+-
dependent manner.  The V2R peptide (L337-S357, RGRm) was titrated into a solution of 
15N-enriched calmodulin in the (a) presence (150µM calmodulin) and (b) absence 
(190µM calmodulin) of calcium.  The panels show regions of the 15N-1H HSQC NMR 
spectra of free CaM (black) overlayed with spectra of CaM complexed with 1.5 molar 
equivalents of RGRm (red).  Arrows highlight chemical shift perturbations caused by 
binding of the RGRm.  Taken from Nickols et al. 2004. 
 
 
 
Figure A.1a shows a selected region of the two-dimensional 15N-1H heteronuclear 
single quantum correlation NMR spectra obtained for Ca2+-loaded calmodulin in the ab-
sence (black) and presence (red) of 1.5 molar eq of the RGRm peptide, whereas Figure 
A.1b shows the corresponding spectra for the apo (Ca2+-free) protein.  The observation 
that many peaks shift position when the peptide is present in Figure A.1a but not Figure 
A.1b reveals that RGRm binds to calmodulin in a Ca2+-dependent manner, corroborating 
the previous findings by other methods.  
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The changes in NMR signals over the course of the titration of RGRm into 
calmodulin can be used to estimate the in vitro binding affinity of the peptide for Ca2+-
calmodulin.  However, a linear change in peak position as a function of peptide concen-
tration that saturated at a peptide:protein ratio of 1:1 indicated that the dissociation con-
stant (Kd) must be at least 100-fold lower than the protein concentration of 150 µM.  Thus, 
the Kd of RGRm for calmodulin is 1.5 µM.  
 
Discussion 
The study presented here was performed in the course of starting to work with 
calmodulin for some of the other projects described in this thesis.  The work done was a 
good introduction to performing peptide binding studies on calmodulin and helped char-
acterize an interesting interaction.  As it turns out and was described in the paper, the 
regulation of this GPCR by calmodulin is important for V2R-mediated calcium release. 
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APPENDIX B 
 
 BINDING CONSTANT CALCULATIONS 
 
Introduction  
 The art of calculating binding constants from data is an old one, one which re-
quired the use of certain mathematical tricks before the advent of significant computing 
power at the desktop to avoid nonlinear regression analysis.  This appendix explains and 
derives some of the basic concepts and equations involved in the calculatioin of single-
site binding constants taking advantage of the computing power available to us today.  
While the corresponding equations for multiple site binding are substantially more com-
plicated and not covered here, the basic approach is the same. 
 
What is a binding constant? 
 It has long been recognized in chemistry that, in solution, most salts only dissoci-
ate partially in solution.  Exceptions to this rule include strong acids like HCl and a few 
other salts like sodium chloride.  For salts that do not dissociate completely, the extent of 
dissociation under a given set of conditions for a given concentration of salt is constant.  
We can therefore define for salts a dissociation constant (Kd) which for the hypothetical 
salt of P+ and L- is the ratio: 
  Kd = [Pfree] [Lfree] / [PL] (1) 
where the brackets indicate to "use the concentration of" the species inside the bracket.  If 
you think a little bit about this equation, you will recognize that salts which remain 
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mostly associated in solution will have high concentrations of PL and low concentrations 
of free species.  This makes Kd very small.  Salts which are mostly dissociated, on the 
other hand, will have the opposite ratio of free to bound species and Kd will be large. 
 This hypothetical discussion of the behavior of salts is equally applicable to the 
interation between proteins and their interaction partners, usually referred to as their 
ligands.  The exact same equation is used to describe their tendency to interact with each 
other; the Kd is a good measure of the extent of this tendency because one may easily and 
quantitatively compare these tendencies using their dissociation constants.  Some, myself 
included, therefore also refer to the dissociation constant as the binding constant or the 
affinity of the interaction. 
 
How does one measure Kd? 
 In order to experimentally ascertain the value of the dissociation constant, one 
needs to be able to measure the ratio of free to bound species in solution - a measurement 
that it is usually impossible to make directly. 
 Instead, a researcher investigating binding affinities will usually have some indi-
cator of the concentration of bound species PL.  For example, in this dissertation both 
NMR and fluorescence data were used to monitor the concentration of bound species.  
Since the researcher also knows how much total protein Ptot and ligand Ltot she has added, 
she can define Pfree in terms of Ptot and PL: 
  [Pfree] = [Ptot] - [PL] (2) 
and the equivalent equation for the ligand: 
  [Lfree] = [Ltot] - [PL] (3) 
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Substituting (2) and (3) into (1) yields: 
 Kd = ([Ptot] - [PL]) ([Ltot] - [PL]) / [PL] (4) 
Some simple algebraic rearrangements: 
  Kd [PL] = ([Ptot] - [PL]) ([Ltot] - [PL]) (5) 
  Kd [PL] = [Ptot][Ltot] - [Ptot][PL] - [Ltot][PL] + [PL]2 (6) 
  [Ptot][Ltot] - [Ptot][PL] - [Ltot][PL] + [PL]2 - Kd[PL] = 0 (7) 
  [PL]2 - ([Ptot] + [Ltot] + Kd)[PL] + [Ptot][Ltot] = 0 (8) 
This last rearrangement yields an equations in the form of the quadratic formula.  Of the 
two  
 
solutions to an equation an equation of this form, only one means something physically: 
                                                                       ___________________________ 
 [PL] = -0.5 × ( [Ptot] + [Ltot] + Kd + √ ([Ptot] + [Ltot] + Kd)2 - 4[Ptot][Ltot]  )  (9) 
 Armed with this equation, let us now return to a discussion of the experimental 
approach to the calculation of Kd.  As mentioned, a researcher may use a technique like 
fluorescence to measure the amount of bound species in solution.  Technically, these 
measurements do not give [PL] directly, but instead give a measure of the ratio of [PL] to 
[Ptot].  
 For example, let us suppose that we are using fluorescence to measure the binding 
of a small molecule to our favorite protein.  In the absence of ligand, the protein gives a 
response of 1000 fluorescence units.  Call this response Q0.  Suppose that we then incre-
mentally add the small molecule ligand until the fluorescence signal no longer changes.  
The response at this point is 800 fluorescence units.  Call this response Qmax.  Because the 
binding of ligand to protein causes the drop in fluorescence, the fluorescence response Q 
at any point during the addition of ligand reflects the ratio of bound protein to total pro-
tein.  We can put this into equation form: 
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  Q = Q0 + (Qmax - Q0) ([PL] / [Ptot]) (10) 
Substituting [PL] from (9) into (10) and rearranging yields: 
                                                                           ________________________ 
 Q = Q0 + (Q0-Qmax)([Ptot]+[Ltot]+Kd+√([Ptot]+[Ltot]+Kd)
2-4[Ptot][Ltot] )/2[Ptot] (11) 
 This is the equation used to calculate binding constants.  After doing a full titra-
tion, a researcher will know total protein concentration Ptot, the response Q as he varies 
the ligand concentration, Q0 from his first data point, and Qmax which is the response pla-
teau.  By using nonlinear regression analysis on his data set using this equation, he will 
be able calculate Kd.   
 Another very useful application of this equation is the simulation of binding 
curves.  If a researcher knows approximately what Kd she expects the affinity of an inter-
action to be, she may set arbitrary values for Q0 nd Qmax and simulate the expected bind-
ing curve for adding ligand to a certain concentration of protein.  This will reveal how 
much ligand will be needed to “saturate” (reach plateau) and what the binding curve will 
look like. 
 
What can cause problems in measuring Kd? 
 While the theoretical treatment above makes measurement of binding constants 
seem straightforward (if not easy), a number of issues can confound the process.  It is 
worthwhile to explore some of these practical issues which arise from theoretical analysis 
of these equations. 
 First, it is absolutely essential to have a reasonable estimate of the protein and 
ligand concentrations.  Without this information, it is impossible to analyze titration data 
because basic information is missing.  I say “reasonable estimate” because, based on 
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simulations, altering the protein concentration ± 10% does not alter the calculated bind-
ing constant very significantly.  Additionally, if the protein concentration is not known 
very accurately, most or all programs able to perform nonlinear regression analysis will 
allow the user to let the protein concentration (or any other variable in the equation, for 
that matter) “float” in order to optimize curve fitting. 
 This brings up a second point.  During the fitting process, the user must be very 
careful to set the initial parameters for curve fitting as close as possible to the expected 
values.  Otherwise the analysis, which is an iterative process, may get stuck in a local 
minimum and give some very strange results.  Users should also always inspect the curve 
as compared to their data.  This will immediately show whether the results of the curve 
fitting are way off.  It may not, on the other hand, reveal if analysis was done correctly. 
 A third set of problems can arise from the experimental conditions picked for the 
titration.  This is an issue that may not be obvious from a cursory inspection of the equa-
tions, but will come to light after doing a series of simulations and examining the binding 
curves that result from various combinations of Kd and Ptot.  These simulations reveal that 
when the selected protein concentration, in units of molarity, is much larger than the 
binding constant, which also has units of molarity, then the binding curves become very 
steep and linear and saturate at 1:1 protein:ligand ratio.  This makes sense in terms of the 
equations; small Kd means strong affinity, and at higher protein concentrations every 
molecule of protein will immediately bind every single molecule of ligand.  This situation 
is not conducive to the calculation of an accurate binding constant, because the binding 
curves for very very strong, very strong, and strong affinities all look about the same at 
protein concentrations greater than 100 times Kd.  Therefore, linear binding curves with 
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saturating response at 1:1 protein:ligand concentration are really only good for estimating 
an upper limit on the binding affinity, e.g. “the Kd is no weaker than --- µM.” 
 Similarly, working with protein concentrations much smaller than the Kd can be 
problematic.  This is because reaching saturation requires a substantial excess of ligand in 
this case.  For example, say a protein has an affinity of 8 mM for a ligand.  In order to 
obtain a reasonably full binding curve at a protein concentration of 64 uM, the researcher 
will need to get to a ligand concentration of nearly 90 mM.  Under these conditions, it is 
possible that someone may miss an interaction during an initial test because they did not 
“go out far enough.” 
 Because of these problems, it is a good idea to get an estimate of the affinity in 
advance of starting to make measurements in earnest.  The optimal range of protein con-
centrations to use in affinity measurements is within an order of magnitude on either side 
of the Kd, e.g. for a Kd of 1 µM, work between 100 nM and 10 µM.   
 A final consideration is that of the experimental technique used.  Each spectro-
scopic method has its advantages and disadvantages.  NMR is useful for weaker interac-
tions (> 100 uM) but doesn’t have the sensitivity to measure stronger affinities at appro-
priate protein concentrations.  Even if it was sensitive enough, NMR is also confounded 
by exchange effects; stronger interactions manifest as peaks broadened to nothing or as a 
new set of signals, which makes analysis of that type of data more difficult or impossible.  
Fluorescence, because of the intrinsically higher sensitivity of optical spectroscopic tech-
niques, is able to measure affinities in the nM range but is subject to dilution effects and 
photobleaching.  Also, significantly complication can arise with the use fluorescence if 
both binding components have the same fluorophore (e.g. both contain tryptophan). 
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Isothemal titration microcalorimetry (ITC) is a good technique for measuring a 
wide range of affinities and is also able to distinguish enthalpic and entropic contribu-
tions to binding, and also the stoichiometry of binding if this information is not known.  
This technique is technically challenging, however, and very sensitive to problems like 
buffer mismatch.  The data collected in ITC experiments is an integral representing the 
heat released or absorbed by the binding of ligand to target.  The data collected is the first 
derivative of data collected by other methods; there are two methods for calculation of 
binding constants from this data.  The first option is to numerically integrate the data set 
and analyze it using the binding equation described above, e.g. for each addi-
tion/injection, the net “response” is the integral from 0 injections to that injection.  A 
graph of this data will look much like a normal binding curve.  The second, and better, 
option is to analyze the heat data directly by fitting to an equation representing the first 
derivative.  While these equations will not be covered here, ITC equipment generally 
comes with software capable of performing nonlinear regression analysis directly on ITC 
data and additionally calculates n (stoichiometry), ∆H, ∆S, and ∆G. 
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APPENDIX C 
 
MATERIALS AND METHODS 
 
Computation 
For Chapter II, multiple sequence alignments and analyses were done with AMPS 
and AMAS (Livingstone and Barton 1993).  Threading calculations were performed 
usingTHREADER 3.3 (Jones et al. 1992), which identifies the known 3D structures that 
best accommodate a given sequence.  The library of 3D structural templates (tertiary fold 
templates) had a representative for all unique 3D protein structures reported in the then 
current PDB database.  The molecular graphics package MOE (2002) was used for all 
structure-based sequence alignments and homology modeling (Figure 2.1b,c).  For the 
molecular models, amino acid side chains were built onto the consensus backbone (Fig-
ure 2.1b) using a systematic conformational search procedure to select optimal side chain 
rotamers (Soss 2002). PDB identifiers used for model generation: 1C07 (human Eps15), 
1C7V (Ca2+-bound C-terminal domain of calcium vector protein), 1EXR (Ca2+-bound 
calmodulin), 1BJF (neurocalcin), and 1TRF (troponin C).  The starting structure was re-
fined with conjugate gradient energy minimization and assessed for structural integrity.  
The program PROCHECK was used for structure assessment (Laskowski et al. 1993). 
 
Subcloning 
 All bacterial expression constructs were generated using standard molecular biol-
ogy techniques to insert a PCR amplified fragment of DNA into a vector.  Briefly, PCR is 
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used to amplify the coding region of a gene of interest from a cDNA or other template.  
The primers also include in-frame extensions to the coding region at the 5’- and 3’- ends, 
which incorporate restriction digestion sites, stop codons, and possibly other elements 
into the amplified fragment.  Following restriction digest of the fragments and of the vec-
tor, the two pieces are mixed and briefly exposed to 65 ºC before being incubated to-
gether at 18 ºC with T4 ligase.  The incubation mixture is then used to transform ultra-
competent bacteria and plated onto agar with appropriate antibiotic selection depending 
on the antibiotic resistance gene found on the vector.  Single colonies are then grown up 
in small volume cultures (3-5 mL LB + antibiotic) and the plasmid isolated from these 
cultures.  The plasmid is DNA sequenced to verify the orientation and frame of the insert 
as well as to verify that the coding region is free of mutations resulting from PCR ampli-
fication. 
 Table I lists the constructs mentioned in this thesis and indicates the vector into 
which they were inserted, the primers used for amplification, and some other relevant in-
formation about the vector and/or construct. 
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Mutagenesis 
 Site directed mutagenesis was used for the generation of a number of mutant con-
structs described in this thesis.  This was generally performed using a Quikchange 
(Stratagene) PCR-based strategy.  The strategy calls for generating ~30 bp forward and 
reverse primers, precisely matching the template plasmid except for the desired muta-
tion(s) or insert.  We performed low copy PCR (16-18 cycles, 55 ºC anneal) using a high-
fidelity thermostable DNA polymerase (Vent; PfuUltra may also be used).  The template 
plasmid must be grown up in and purified from bacteria; this methylates the DNA.  This 
is important because following low-copy PCR, the parental plasmid is digested by DpnI, 
which only cleaves methylated DNA.  The PCR mixture is transformed into ultracompe-
tent bacteria and plated; plasmids are purified from cultured colonies and are then se-
quenced to ensure the presence of the desired mutation and the absence of secondary mu-
tations. 
 Table II summarizes the mutants used in these studies, and includes information 
about the primers and templates used in the generation of these mutants.  The table only 
indicates one of the primers used in the generation of the mutant; in ALL cases, the re-
verse complement is the other primer. 
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Protein Production 
 hH1-CTD constructs, MBP-IQ fusion proteins, and His-III-IV linker were over-
expressed in E. coli host BL21 (DE3) cells (Novagen).  Unlabeled protein was prepared 
by growing cells in LB medium (10 g tryptone, 10 g NaCl, 5 g yeast extract per liter) at 
37 ºC.  Uniform 15N-labeling for NMR was achieved by growth at 37 ºC in M9 minimal 
medium containing 15NH4Cl as the sole nitrogen source.  An exception to this was the 
growth of hH1-CTD-120 (Chapter III), which was grown and expressed at 30 ºC. 
 In all lysis steps described below, protease activity was inhibited by supplement-
ing the lysis buffer with Roche Mini EDTA-free protease inhibitor tablets (Roche).  The 
pH values always indicate the final adjusted pH after all components are added. 
 His-tagged proteins, including all MBP fusion constructs described here, were 
purified by NiNTA affinity chromatography (Qiagen, Valencia, CA).  Briefly, the proto-
col called for lysis (using lysozyme and sonication) into 20 mM Tris buffer with 20 mM 
CaCl2 and 5 mM BME at pH 7.5, 30 mL per liter of growth.  The lysate was loaded onto 
a NiNTA column and washed with lysis buffer supplemented with 30-50 mM imidazole.  
Elution was achieved with a step to 300 mM imidazole. 
 Protein prepared for Chapter II (hH1-CTD-148 WT and mutants) were further 
purified as follows.  NiNTA eluate was dialyzed into imidazole free lysis buffer over-
night and cleaved the following day by thrombin.  Thrombin was removed by passing the 
cleavage buffer over benzamidine sepharose and the cleaved protein was separated from 
MBP and other contaminants by final purification using anion exchange chromatography 
(MonoQ, 20 CV gradient from lysis buffer into lysis buffer + 2M NaCl, protein elution at 
15-30 mS/cm conductivity, Amersham Biosciences). 
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For the MBP-IQpeptide fusion protein used in Chapter II, after NiNTA chroma-
tography the protein was dialyzed against 50 mM Tris, 150 mM NaCl, 2 mM DTT, pH 
7.5 to remove imidazole.  The protein was then cleaved using rhinovirus 3C protease for 
3 hours at room temperature.  The cleavage reaction leaves an exogenous Gly-Pro dipep-
tide at the amino terminus.  The reaction mixture was adjusted to 0.1% TFA and loaded 
directly onto a C18 column for RP-HPLC purification in two steps.  In both steps, start-
ing buffer was MilliQ water + 0.05% TFA, and the final buffer was 100% ACN + 0.05% 
TFA.  The first step was a shallow gradient on a 100 mL C18 column, eluting over a 5 
CV gradient.  Fractions containing peptide of interest (as determined by MALDI-TOF 
mass spectrometry) were pooled and loaded onto a smaller 20 mL C18 column and eluted 
over a 20 CV gradient.  The presence of peptide was verified by MALDI-TOF MS and 
the purity assessed by SDS-PAGE.  The peptide was then lyophilized and stored at -30 ºC 
for subsequent use. 
 The untagged constructs expressed from the pSV271 vector were purified by two 
different protocols, depending on whether they expressed in the soluble fraction or in in-
clusion bodies.  All hH1-CTD-93 constructs (His-tagged, untagged, wild-type and mu-
tants) and hH1-CTD-120 expressed at 30 ºC were soluble.  All hH1-CTD-148 and hH1-
CTD-153 constructs were insoluble when expressed at 37 ºC; unlike the hH1-CTD-153 
other constructs, the hH1-CTD-153-IQAA mutant was soluble if expressed at 30 ºC but 
was expressed at 37 ºC with the other hH1-CTD-153 constructs for parallel processing 
purposes. 
 Those expressing in the soluble fraction were lysed (using lysozyme and sonica-
tion) into 20 mM Tris, 5 mM BME, 20 mM CaCl2, 2M NaCl at pH 7.5 and loaded di-
115 
rectly onto phenyl sepharose FF (Amersham Biosciences).  After a 10 CV wash, the pro-
tein was eluted with a single step to MilliQ water.  The eluted protein was loaded onto an 
anion exchange column (Q sepharose, Amersham Biosciences) and eluted by a 20 CV 
gradient from MilliQ water to lysis buffer.  Fractions were analyzed by SDS-PAGE and 
fractions containing the protein were pooled and concentrated in Centricon devices to < 2 
mL (3K MWCO for hH1-CTD-93 constructs, 5K MWCO for hH1-CTD-120).  The con-
centrated protein was then loaded onto a 120 mL gel filtration (Superdex 75) column.  
Fractions analyzed by SDS-PAGE were judged to be > 95% pure; if not, a polishing step 
using a monodispersed anion exchange medium such a MonoQ (Amersham Biosciences) 
was included. 
hH1-CTD proteins expressing in the insoluble fraction were purified by first iso-
lating the inclusion bodies.  Cell pellets were lysed in 20 mM Tris, 5 mM BME, 20 mM 
CaCl2, 300 mM NaCl, 0.1% Triton-100 at pH 7.5 with lysozyme and sonication (30 mL 
of lysis buffer per liter of growth).  Following centrifugation, the pellet was retained and 
resuspended in 30 mL of lysis buffer without lysozyme by sonication.  Following cen-
trifugation again, the pellet was resuspended in 30 mL of 20 mM Tris, 5 mM BME, 20 
mM CaCl2, 300 mM NaCl at pH 7.5 by sonication.  Centrifugation yielded a thoroughly 
washed pellet, at about 60% purity of the target protein.  The pellet was solubilized in 5 
mL 6M guanidine hydrochloride and rapidly diluted to 50 mL with 20 mM Tris, 5 mM 
BME, 20 mM CaCl2.  This removed a significant fraction of contaminants, which precipi-
tated out of solution and were removed by centrifugation and filtering.  The supernatant 
was dialyzed against 20 mM Tris, 5 mM BME, 20 mM CaCl2 pH 7.5, which removed 
further contaminants by precipitation, and purified via anion exchange chromatography 
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on a monodispersed medium over 20 CV (MonoQ, SourceQ; Amersham Biosciences).  
Buffers for the chromatography were 20 mM Tris, 5 mM BME, 20 mM CaCl2, pH 7.5 
(starting buffer) and 20 mM Tris, 5 mM BME, 20 mM CaCl2, 2M NaCl, pH 7.5 (final 
buffer). 
For the studies described in Appendix A, a peptide fragment of the V2R C termi-
nus (339LLSSARGRTPPSLGPQDES357 with the cysteines normally acylated in V2R 
(Cys-341 and Cys-342) mutated to serine) was ordered from Genemed Synthesis and sub-
sequently purified by reversed-phase high pressure liquid chromatography.  Removal of 
the single major contaminant from the eluted peptide was confirmed by electrospray ioni-
zation-mass spectrometry and matrix-assisted laser desorption ionization-mass spectrome-
try.  The final peptide was lyophilized and resuspended at 10 mg/ml in 500 mM Tris, pH 
7.0.   
For the experiments in Chapter IV and Appendix A, human calmodulin was ex-
pressed from a bacterial expression vector kindly provided by Eva Thulin (University of 
Lund, Sweden).  The construct was transformed into BL21(DE3)pLysS Escherichia coli, 
and the bacteria were grown in M9 minimal media supplemented with 15NH4Cl.  The bac-
teria were grown and induced with isopropyl-β-D-thiogalactopyranoside (IPTG) as de-
scribed previously.  Briefly, the growth protocol calls for serial dilution of bacteria grow-
ing at 30 °C, allowing the bacteria to double prior to each dilution.  Following induction 
at 1 mM IPTG, the bacteria are incubated at 37 °C until growth stops.  The protein was 
purified as described previously by Ca2+-dependent binding of calmodulin to phenyl-
Sepharose (Vogel et al. 1983).  Samples were loaded in 1 mM CaCl2 and eluted at 1 mM 
EDTA. 
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Electrophysiology 
 The following experiments were performed by Tammy Wingo, Ph.D. with the 
assistance of Svetlana Stepanovic in the laboratory of Jeffrey Balser, M.D., Ph.D.  Cul-
tured tsA201 cells were transiently transfected with either WT or mutant (D1790G, 4X) 
cDNA (1.5 µg).  Green cells were selected for electrophysiological analysis 24 hours 
later.  The cells were maintained on culture plates using Dulbecco’s Minimum Essential 
Medium (DMEM) with FBS (10%) and 1% Pen-Strep.  In experiments where both the α 
and β subunits were used, cultured tsA201 cells were co-transfected with a 1:1 molar ra-
tio of the Na+ channel β1 subunit (provided by A. George, Vanderbilt University). 
INa was recorded at 22 °C and analysed (mean ± SEM) as described previously 
(Tan et al. 2001).   The voltage-clamp protocol used to measure steady state channel 
availability are described in the text or figure legends of Chapter II.  A Boltzmann func-
tion (y = [(A1 – A2)/(1 + e(x - x0/dx))] + A2) was fitted to the availability curves to determine 
the membrane potential eliciting half-maximal inactivation (V1/2), where A1 and A2 are 
initial and final values, x0 is equivalent to V1/2, and dx represents the time constant.  All 
experiments were performed 4 to 6.5 minutes after membrane rupture to allow full 
equilibration of the pipette solutions. 
The bath solution contained: 145 mM NaCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM 
MgCl2, and 10 mM HEPES (pH 7.35 with CsOH). The pipette solution used to mimic 
Ca2+-free conditions contained (in mM): NaF 10, CsF 100, CsCl 20, BAPTA 20, HEPES 
10 (pH 7.35 with CsOH).  For the concentrations of free Ca2+ used in the dose-response 
analysis, 20 mM BAPTA was used with 0 CaCl2, 8.94 mM CaCl2, 10.9 mM CaCl2, and 
13.4 mM CaCl2 to create solutions where the free Ca2+ concentrations were 0, 100, 150, 
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and 250 nM, respectively (Bers et al. 1994). For higher (µM) Ca2+ concentrations, the 
BAPTA concentration was reduced to 1 mM to avoid precipitation of the pipette solution.  
For concentrations of 1 µM and 10 µM free Ca2+, 1 mM BAPTA was used with 0.9 mM 
Ca2+ and 1.0 mM Ca2+, respectively. The availability curves indicate a substantial portion 
of the voltage shift occurred between 0 and 250 nM, where the BAPTA concentration is 
fixed, suggesting the Ca2+-dependent changes observed do not arise from lowering the 
BAPTA concentration to achieve high (µM) free Ca2+. 
 
Sample Preparation for Spectroscopy 
In Chapter II, calcium-free hH1-CTD-148 protein samples were prepared in two 
ways. (1) Dialysis against: 10 mM HEPES, 1 mM BME, 10 mM EDTA, pH 8.0; fol-
lowed by three further dialysis steps in EDTA-free Chelex-100 treated buffer.  (2) Three 
steps of concentration and resuspension in: 10 mM HEPES, 1 mM BME, 1 mM BAPTA, 
pH 8.0; followed by three steps of concentration and resuspension in BAPTA-free 
Chelex-100 treated buffer. 
For the studies described in Chapter III, hH1-CTD samples were decalcified, then 
exchanged into the following buffers: [Calcium-loaded] – 20 mM Tris, 5 mM BME, 20 
mM CaCl2, pH 7.5; [Apo] – 20 mM Tris, 5 mM BME, 2 mM BAPTA, pH 7.5; [EGTA] – 
20 mM  Tris, 5 mM BME, 2 mM EGTA, pH 7.5; [Mg2+] – 20 mM Tris, 5 mM BME, 20 
mM MgCl2, pH 7.5.  Atomic absorption was used to measure residual calcium in protein 
decalcified by BAPTA (Galbraith Laboratories Inc., Knoxville, TN).  This analysis 
showed that calcium was reduced to below the detection limit (< 17 µM) by exchange 
into BAPTA. 
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Trichloroacetic acid (TCA) precipitation used in Chapters III and IV to remove 
calcium was performed in three rounds following the protocol of Haiech and colleagues 
(Haiech et al. 1981).  Briefly, this protocol takes advantage of the fact that acidic residues 
are critical for binding calcium ions.  Strong acidification of the protein solution using 
TCA protonates these acidic residues and prevents chelation of the calcium ion.  TCA 
also causes the protein to precipitate.  The precipitated protein can then be recovered by 
centrifugation and rinsed with Chelex-treated buffer.  The precipitate is solubilized in 1M 
Tris-base and refolded by adjustment of the pH to 7.5.  This process is repeated twice 
more to ensure complete removal of calcium.  Following TCA precipitation, protein solu-
tions were adjusted to reduce the quantity of Tris in the buffer and to add BME.   
NMR titrations were performed at 150 mM Tris, 3.7 mM BME, pH 8.0 at protein 
concentrations varying between 100 µM and 1 mM.  Intrinsic fluorescence titrations were 
performed at 40 mM Tris, 4.5 mM BME, pH 8.0 at a protein concentration of approxi-
mately 1 µM.   
For the studies in Chapter IV and Appendix A, calmodulin was exchanged into 
(apo) 20 mM bis-Tris, 100 mM KCl, 1 mM DTT, 2 mM EGTA, pH 6.5 or (Ca2+-loaded) 
20 mM bis-Tris, 100 mM KCl, 1 mM DTT, 20 mM CaCl2, pH 6.5.  The calmodulin con-
centration was determined by A276, using an extinction coefficient ε = 3006 M-1 cm-1.   
Intrinsic fluorescence 
Steady-state fluorescence emission spectra were recorded at ambient temperature 
using a SPEX FLUOROMAX spectrofluorometer (Spex Instruments SA).  For calcium 
affinity measurements, a 3.2 mL quartz cuvette was prepared by soaking in EDTA, 
EGTA, or BAPTA, followed by thorough rinsing with Chelex-100 treated H2O.  
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Calmodulin-IQ affinity measurements in Chapter IV were likewise conducted in 1.0 mL 
quartz cuvettes pre-soaked in the appropriate apo or Ca2+ containing buffer. 
In Chapter II, scanning was done from 300-375 nm (λexcit = 280 nm) and 320-375 
nm (λexcit = 295 nm), with slit-widths set to 5 nm.  Calcium-free protein in a buffer con-
taining 10 mM HEPES and 1 mM BME at pH 7.0 was used for titrations.  Protein con-
centration was determined by amino acid analysis.  Binding constants were obtained by 
fitting to a standard binding equation using CaLigator 1.05 (Andre and Linse 2002). 
 In Chapter III, scanning was done from 320-380 nm (λexcit = 295 nm) with slit-
widths set to 5 nm.  Calcium-free protein in a buffer containing 20 mM Tris and 5 mM 
BME at pH 7.5 was used for titrations performed by adding small aliquots of calcium.  
Binding constants and best-fit curves were obtained by fitting to a standard binding equa-
tion using CaLigator 1.05 or Mathematica 4.0 (Wolfram Research).  Fits and data were 
plotted in Microsoft Excel. 
 In Chapter IV, constant wavelength analysis was used to measure calcium binding 
affinities, monitoring tryptophan fluorescence at 345 nm with excitation at 280 nm and 
295 nm.  Constant wavelength analysis was also used to measure calmodulin affinity for 
IQ peptides, monitoring tyrosine fluorescence at 320 nm with excitation at 277 nm. 
 
Circular dichroism (CD) 
CD spectra were recorded at ambient temperature over a range of 190-260 nm us-
ing a Jasco J-810 spectropolarimeter (Jasco, Easton, Maryland).  The measurements were 
carried out in 1 mm quartz cuvettes prepared by soaking in EDTA, EGTA, or BAPTA, 
followed by thorough rinsing with Chelex-100 treated H2O. 
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Nuclear magnetic resonance (NMR) 
Gradient enhanced 15N-1H HSQC NMR spectra were recorded at 27 ºC on 
AVANCE Bruker spectrometers operating at 500 and 600 MHz equipped with Cryo-
Probes.  Acquisition parameters varied, but were generally 4, 8, 16, or 32 scans per real 
or imaginary point in the indirect dimension, with 64 or 128 complex points (128 or 256 
F.I.D.) total in the indirect dimension.  Sweep width in 1H was 15 ppm, and in 15N incre-
ments were selected to set a sweep width of 35 ppm.  Solutions for Chapter II experi-
ments contained 0.1-1.0 mM 15N-enriched protein in a buffer containing 10 mM HEPES, 
1 mM BME, 1 mM CaCl2, pH 8.0, 90% H2O/10%D2O.  The NMR spectra were proc-
essed and analyzed using XWinNMR (Bruker, Germany) and Sparky (Goddard and 
Kneller).  A sinebell squared window function and zero filling by a factor of four in the 
indirect dimension were generally applied prior to Fourier transform.  Spectra were plot-
ted in the programs used for data analysis. 
Experiments described in Appendix A were conducted on a Bruker AVANCE 
500 MHz spectrometer equipped with a CryoProbe.  Two-dimensional 15N-1H heteronu-
clear single quantum correlation experiments were performed at 25 °C, acquiring four 
scans per increment and 512 points in the indirect (t1) dimension.  NMR data were proc-
essed and analyzed in XWinNMR (Bruker). 
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APPENDIX D 
 
NMR SPECTRA 
 
Introduction 
 The following 15N-1H HSQC NMR spectra are the full or almost full plots of 
spectra that, when mentioned or shown in a figure, only a zoomed part of the spectrum 
was shown.  These zooms were chosen for various reasons.  In some cases, it was to em-
phasize particular regions of the spectrum, such as downfield regions indicating the pres-
ence of folded protein.  In other cases it was show a representative example of phenom-
ena occurring throughout the spectrum – slow/intermediate/fast exchange during a titra-
tion, for example.  Finally, in some cases spectra were not included for space or aesthetic 
reasons.  Here, however, deference has been given to scientific content over aesthetic 
considerations.  In some cases, spectra with poor S/N have been plotted such that noise or 
processing artifacts are visible.  Likewise, in some of the low S/N BAPTA spectra noise 
ridges appear due to incomplete suppression of non-15N-linked 1H signals.  While these 
ridges can be removed during processing, such removal also suppresses or removes real 
peaks. 
 Please note that many of the hH1-CTD spectra exclude a single dispersed peak 
which is found extremely downfield at 11.28 ppm in 1H and 129.3 in 15N.  The decision 
was made to exclude the peak because plotting it generally sacrifices clarity of the rest of 
the spectrum. 
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Figure D.1: Spectrum of hH1-CTD-148.  See Chapter III for details. 
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Figure D.2: Spectrum of hH1-CTD-120.  See Chapter III for details. 
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Figure D.3: Spectrum of hH1-CTD-93.  See Chapter III for details. 
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Figure D.4: Spectra of hH1-CTD-93, BAPTA-apo (blue) and Ca2+-loaded (red).  See 
Chapter III for details. 
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Figure D.5: Spectra of hH1-CTD-93.  BAPTA-apo (dark blue), TCA-apo (light blue).  
See Chapter III for details. 
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Figure D.6: Spectra of hH1-CTD-93.  BAPTA-apo (dark blue), EGTA-apo (light blue).  
See Chapter III for details. 
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Figure D.7: Spectra of hH1-CTD-93.  BAPTA-apo (dark blue), MgCl2-loaded (green).  
See Chapter III for details. 
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Figure D.8: Spectra of hH1-CTD-93-D1790G.  BAPTA-apo (dark blue), Ca2+-loaded 
(red-yellow).  BAPTA noise ridges are visible.  See Chapter III for details. 
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Figure D.9: Spectra of hH1-CTD-93-F1791A.  BAPTA-apo (dark blue), Ca2+-loaded 
(red-yellow).  Faint BAPTA noise ridges are visible.  See Chapter III for details. 
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Figure D.10: Spectra of hH1-CTD-93-M1793G.  BAPTA-apo (dark blue), Ca2+-loaded 
(red-yellow).  See Chapter III for details. 
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Figure D.11: Spectra of hH1-CTD-93-E1799A.  BAPTA-apo (dark blue), Ca2+-loaded 
(red-yellow).  See Chapter III for details. 
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Figure D.12: Spectra of hH1-CTD-93 collected during a calcium titration.  See Chapter 
III for details. 
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Figure D.13: Spectra of hH1-CTD-148 collected during a calcium titration.  Because of 
µM affinity binding, intermediate exchange causes significant peak broadening.  See 
Chapter III for details. 
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Figure D.14: Spectra of apo-hH1-CTD-93 ± IQ motif.  Absence of IQ motif (blue).  Plus 
IQ motif (red).  See Chapter IV for details. 
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Figure D.15: Spectra of Ca2+-hH1-CTD-93 ± IQ motif.  Absence of IQ motif (blue).  
Plus IQ motif (red).  See Chapter IV for details. 
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Figure D.16: Spectra of apo-hH1-CTD-153 (blue) and Ca2+-hH1-CTD-153 (red).  See 
Chapter IV for details. 
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Figure D.17: Spectra of apo-hH1-CTD-153-A1924T (blue) and Ca2+-hH1-CTD-153-
A1924T (red).  See Chapter IV for details. 
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Figure D.18: Spectra of apo-hH1-CTD-153-IQ/AA (green-blue) and Ca2+-hH1-CTD-
153-IQ/AA (red-yellow).  See Chapter IV for details. 
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Figure D.19: Titration of calcium into TCA precipitated apo-hH1-CTD-153-IQ/AA.  See 
Chapter IV for details. 
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Figure D.20: Spectra of apo-calmodulin ± IQ motif.  Absence of IQ motif (blue).  Plus 
IQ motif (red).  Usable transferred assignments included.  See Chapter IV for details. 
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Figure D.21: Spectra of Ca2+-calmodulin ± IQ motif.  Absence of IQ motif (blue).  Plus 
IQ motif (red).  Some transferred assignments included.  See Chapter IV for details. 
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